論文業績一覧
1.

一元化登録（ 2009年4月以降）データ利用申請・ WG研究

論文業績
刊・号・
頁

業績
番号

54-7.

U1

2011

25(1):417.

U2

A suggested total size for the cord bloodbanks of Japan.
Successful cord blood transplantation in a
42-day-old boy with infantile Krabbedisease.
Allogeneic hematopoietic stem celltransplantation for acute myeloid leukemiawith t(6;9)(p23;q34) dramatically improves
the patient prognosis: a matched-pairanalysis.

Takanashi M, Tanaka H, Kohsaki M,
Bone Marrow
2011
Nakajima K, Tadokoro K, Nakabayashi M. Transplant46(7):101
4-5.

U3

Yagasaki H, Kato M, Ishige M, Shichino H,
Int J Hematol 2011
Chin M, Mugishima H.

93(4):566-8.

U4Ishiyama K, Takami A, Kanda Y, Nakao S,
Hidaka M, Maeda T, Naoe T, Taniguchi S,
Leukemia
Kawa K, Nagamura T, Atsuta Y, Sakamaki
H.

2012

26(3):461
-4.

U5

6

Prognostic factors for acute myeloid
leukemia patients with t(6;9)(p23;q34) who
underwent an allogeneic hematopoietic
stem cell transplant.

Ishiyama K, Takami A, Kanda Y, Nakao S,
Hidaka M, Maeda T, Naoe T, Taniguchi S,
Leukemia
Kawa K, Nagamura T, Tabuchi K, Atsuta
Y, Sakamaki H.

2012

26(6):141
6-9.

U6

7

Peripheral blood as a preferable source ofFuji S, Nakamura F, Hatanaka K,
stem cells for salvage transplantation in
Taniguchi S, Sato M, Mori S, Sakamaki H, Biol Bloodpatients with graft failure after cord blood
Yabe H, Miyamoto T, Kanamori H, Ueda Y, Marrowtransplantation: a retrospective analysis of
Kawa K, Kato K, Suzuki R, Atsuta Y,
Transplant
the registry data of the Japanese Society
Tamaki T, Kanda Y.
for Hematopoietic Cell Transplantation.

2012

18(9):140
7-14.

U7

2012

119(9):21
41-8.

U8

Blood

2012

119(10):2
409-16.

U9Biol Blood
Marrow
Transplant

論文タイトル

著者

小児へのさい帯血移植.

2

Pre-transplant imatinib-based therapy
Mizuta S, Matsuo K, Yagasaki F, Yujiri T,
improves the outcome of allogeneic
Hatta Y, Kimura Y, Ueda Y, Kanamori H,
hematopoietic stem cell transplantation for Usui N, Akiyama H, Miyazaki Y, Ohtake S, Leukemia
BCR-ABL-positive acute lymphoblastic
Atsuta Y, Sakamaki H, Kawa K, Morishima
leukemia.
Y, Ohnishi K, Naoe T, Ohno R.

4

5

Kanda J, Hishizawa M, Utsunomiya A,
Taniguchi S, Eto T, Moriuchi Y, Tanosaki
R, Kawano F, Miyazaki Y, Masuda M,
Nagafuji K, Hara M, Takanashi M, Kai S,
Blood
Atsuta Y, Suzuki R, Kawase T, Matsuo K,
Nagamura-Inoue T, Kato S, Sakamaki H,
Morishima Y, Okamura J, Ichinohe T,
Uchiyama T.

8Impact of graft-versus-host disease on
outcomes after allogeneic hematopoietic
cell transplantation for adult T-cellleukemia: a retrospective cohort study.

9

Kanda J, Saji H, Fukuda T, Kobayashi T,
Related transplantation with HLA-1 Ag
Miyamura K, Eto T, Kurokawa M,
mismatch in the GVH direction and HLAKanamori H, Mori T, Hidaka M, Iwato K,
8/8 allele-matched unrelated
Yoshida T, Sakamaki H, Tanaka J, Kawa
transplantation: a nationwide retrospective
K, Morishima Y, Suzuki R, Atsuta Y,
study.
Kanda Y.

発行
年

日本さい帯血バンクネットワーク設立10 2009
周年記念 そして明日から

1

3

加藤剛二.

雑誌名

Efficacy and long-term outcome oftreatment for pure red cell aplasia after
10
allogeneic stem cell transplantation frommajor ABO-incompatible donors.

Hirokawa M, Fukuda T, Ohashi K, Hidaka
M, Ichinohe T, Iwato K, Kanamori H,
Murata M, Sakura T, Imamura M, Adachi
S, Suzuki R, Morishima Y, Sakamaki H;
PRCA Collaborative Study Group.

2013

19(7):102
6-32.

U10

Changes in incidence and causes of nonrelapse mortality after allogeneic
hematopoietic cell transplantation in
11 patients with acuteleukemia/myelodysplastic syndrome: ananalysis of the Japan Transplant Outcome
Registry.

Kurosawa S, Yakushijin K, Yamaguchi T,
Atsuta Y, Nagamura-Inoue T, Akiyama H,
Taniguchi S, Miyamura K, Takahashi S,
Bone Marrow
2013
Eto T, Ogawa H, Kurokawa M, Tanaka J, Transplant
Kawa K, Kato K, Suzuki R, Morishima Y,
Sakamaki H, Fukuda T.

48(4):529
-36.

U11

発行
年

刊・号・
頁

業績
番号

Kurosawa S, Yakushijin K, Yamaguchi T,
Recent decrease in non-relapse mortality Atsuta Y, Nagamura-Inoue T, Akiyama H,
due to GVHD and infection after allogeneic Taniguchi S, Miyamura K, Takahashi S,
Bone Marrow
12
2013
hematopoietic cell transplantation in non- Eto T, Ogawa H, Kurokawa M, Tanaka J, Transplant
remission acute leukemia.
Kawa K, Kato K, Suzuki R, Morishima Y,
Sakamaki H, Fukuda T.

48(9):119
8-204.

U12

PBSCT is associated with poorer survival
and increased chronic GvHD than BMT in
13 Japanese paediatric patients with acuteleukaemia and an HLA-matched sibling
donor.

Shinzato A, Tabuchi K, Atsuta Y, Inoue M,
Inagaki J, Yabe H, Koh K, Kato K, Ohta H, Pediatr Blood
2013
Kigasawa H, Kitoh T, Ogawa A, Takahashi Cancer
Y, Sasahara Y, Kato S, Adachi S.

60(9):151
3-9.

U13

Allogeneic hematopoietic stem cell
14 transplantation for intermediate
cytogenetic risk AML in first CR.

Imahashi N, Suzuki R, Fukuda T, Kakihana
K, Kanamori H, Eto T, Mori T, Kobayashi
N, Iwato K, Sakura T, Ikegame K,
Bone Marrow
2013
Kurokawa M, Kondo T, Iida H, Sakamaki Transplant
H, Tanaka J, Kawa K, Morishima Y, Atsuta
Y, Miyamura K.

48(1):5662.

U14

Int J Hematol 2013

98(2):223
-30.

U15

血液事業

35(4):703-5.

U16

Association between decreasing trend in
the mortality of adult T-cellleukemia/lymphoma and allogeneic
Chihara D, Ito H, Matsuda T, Katanoda K,
Blood Cancer
17 hematopoietic stem cell transplants in
Shibata A, Taniguchi S, Utsunomiya A,
2013
JJapan: analysis of Japanese vital statistics Sobue T, Matsuo K.
and Japan Society for Hematopoietic Cell
Transplantation (JSHCT).

3:e159.

U17

Granulocyte colony-stimulating factor
Konuma T, Ooi J, Uchida N, Ogawa H,
combined regimen in cord blood
Ohashi K, Kanamori H, Aotsuka N, Onishi
Haematologic
18 transplantation for acute myeloid leukemia: Y, Yamaguchi H, Kozai Y, Nagamura2014aa nationwide retrospective analysis inInoue T, Kato K, Suzuki R, Atsuta Y, KatoJapan.
S, Asano S, Takahashi S.

99(12):e2
64-8.

U18

Iida M, Fukuda T, Uchida N, Murata M,
Mycophenolate mofetil use after unrelated
Aotsuka N, Minagawa K, Oohashi K,
hematopoietic stem cell transplantation for
19
Fukushima K, Kondo T, Eto T, Miyamotoprophylaxis and treatment of graft-vs.T, Morishima Y, Nagamura T, Atsuta Y,
host disease in adult patients in Japan.
Suzuki R.

2014

28(9):980-9.

U19

Murata M, Nishida T, Taniguchi S, Ohashi
Allogeneic transplantation for primaryK, Ogawa H, Fukuda T, Mori T, Kobayashi
myelofibrosis with BM, peripheral blood orBone Marrow
20
H, Nakaseko C, Yamagata N, Morishima Y,
2014umbilical cord blood: an analysis of theTransplant
Nagamura-Inoue T, Sakamaki H, Atsuta Y,
JSHCT.
Suzuki R, Naoe T.

49(3):355
-60.

U20

20(2):203
-14.

U21

論文タイトル

著者

Feasibility of reduced-intensity
Sawada A, Ohga S, Ishii E, Inoue M,
conditioning followed by unrelated cord
Okada K, Inagaki J, Goto H, Suzuki N,
15 blood transplantation for primary
Koike K, Atsuta Y, Suzuki R, Yabe H,
hemophagocytic lymphohistiocytosis: a
Kawa K, Kato K, Yasutomo K.
nationwide retrospective analysis in Japan.
16

移植に必要なAB型の血漿・血小板製剤の永澤雅秀.
需給動向について.

雑誌名

Clin
Transplant

Hematopoietic stem cell transplantation forinborn errors of metabolism: A report fromthe Research Committee on
Kato S, Yabe H, Takakura H, Mugishima
Transplantation for Inborn Errors of
H, Ishige M, Tanaka A, Kato K, Yoshida N, Pediatr
21 Metabolism of the Japanese Ministry of
Adachi S, Sakai N, Hashii Y, Ohashi T,
Transplant
Health, Labour and Welfare and the
Sasahara Y, Suzuki Y, Tabuchi K.
Working Group of the Japan Society for
Hematopoietic Cell Transplantation.

2013

2016

論文タイトル

著者

雑誌名

発行
年

Kurita N, Gosho M, Yokoyama Y, Kato T,
Obara N, Sakata-Yanagimoto M,
A phase I/II trial of intrabone marrow cord
Hasegawa Y, Uchida N, Takahashi S,
blood transplantation and comparison ofBone Marrow
22
Kouzai Y, Atsuta Y, Kurata M, Ichinohe T,2017
the hematological recovery with theTransplant
Chiba S.
Japanese nationwide database.

刊・号・
頁

業績
番号

52(4):574-9.

U22Comparison of Conditioning with
Fludarabine/Busulfan and
23 Fludarabine/Melphalan in Allogeneic
Transplantation Recipients 50 Years or
Older.

Kawamura K, Kako S, Mizuta S, Ishiyama
K, Aoki J, Yano S, Fukuda T, Uchida N,
Biol Blood
Ozawa Y, Eto T, Iwato K, Kanamori H,
Marrow
Kahata K, Kondo T, Sawa M, Ichinohe T, Transplant
Atsuta Y, Kanda Y.

201723(12):20
79-87.

U23

Impact of a Low CD34+ Cell Dose on
24 Allogeneic Peripheral Blood Stem Cell
Transplantation.

Yamamoto C, Ogawa H, Fukuda T,
Biol Blood
Igarashi A, Okumura H, Uchida N, Hidaka
Marrow
M, Nakamae H, Matsuoka KI, Eto T,
Transplant
Ichinohe T, Atsuta Y, Kanda Y.

201824(4):708
-16.

U24

Impact of HIV Infection on Transplant
Outcomes after Autologous Peripheral
25 Blood Stem Cell Transplantation: A
Retrospective Study of Japanese Registry
Data.

Yoshinaga N, Kanda J, Aisa Y, Hagiwara
S, Mori T, Fukuda T, Ishida Y, Hashimoto Biol Blood
H, Iwato K, Kanda Y, Kurokawa M,
Marrow
Nakazawa H, Ota S, Uchida N, Ichinohe T, Transplant
Atsuta Y, Takaori-Kondo A.

201824(8):159
6-601.

U25

Yoshizato T, Dumitriu B, Hosokawa K,
Makishima H, Yoshida K, Townsley D,
Sato-Otsubo A, Sato Y, Liu D, Suzuki H,
Wu CO, Shiraishi Y, Clemente MJ,
Kataoka K, Shiozawa Y, Okuno Y, Chiba N Engl J Med 2015
K, Tanaka H, Nagata Y, Katagiri T, Kon A,
Sanada M, Scheinberg P, Miyano S,
Maciejewski JP, Nakao S, Young NS,
Ogawa S.

373(1):35
-47.

U26

2018

24(10):21
39-44.

U27

Impact of pretransplant leukemic blast% inbone marrow and peripheral blood on
Ogawa H, Ikegame K, Daimon T, Uchida N,
transplantation outcomes of patients with Fukuda T, Kakihana K, Eto T, Ozawa Y,
Bone Marrow
28
2018
acute myeloid leukemia undergoing
Kanamori H, Hidaka M, Iwato Y, Ichinohe Transplant
allogeneic stem cell transplantation in non- T, Takanashi M, Atsuta Y, Kanda Y.
CR.

53(4):478
-82.

U28

Kawajiri-Manako C, Sakaida E, Ohwada C,
Efficacy and Long-Term Outcomes ofMiyamoto T, Azuma T, Taguchi J, Mori T,
Biol Blood
Autologous Stem Cell Transplantation in
Hasegawa Y, Kondo T, Yujiri T,
29
Marrow
POEMS Syndrome: A Nationwide Survey in Yoshimitsu M, Imada K, Kurahashi S,
Transplant
Japan.
Kahata K, Ichinohe T, Hirokawa M, Atsuta
Y, Nakaseko C.

201824(6):118
0-6.

U29

2017

6(2):10814.

U30

2018

59(3):746-8.

U31

Kawashima N, Iida M, Suzuki R, Fukuda T,
Atsuta Y, Hashii Y, Inoue M, Kobayashi M,
Int J Hematol 2019
Yabe H, Okada K, Adachi S, Yuza Y, Kawa
K, Kato K.

109(4):49
1-8.

U32

26

Somatic Mutations and Clonal
Hematopoiesis in Aplastic Anemia.

Kako S, Fujiwara S, Sato M, Kimura SI,
Safety and Efficacy of Once-Daily
Nakasone H, Ohashi K, Kawakita T,
Biol Blood
27 Intravenous Busulfan in Allogeneic
Maeda T, Morishita T, Suzuki R, Fukuda Marrow
Transplantation: A Matched-Pair Analysis. T, Ichinohe T, Kurata M, Atsuta Y, Kanda TransplantY.

折原勝己, 吾郷浩厚, 奥山美樹, 落合亮
日本造血細日本骨髄バンクドナーの2回骨髄提供に関 一, 澤 正史, 田野﨑隆二, 玉井佳子, 豊嶋
胞移植学会
する検討.
崇徳, 中尾康夫, 日野雅之, 宮﨑泰司, 神雑誌
田善伸, 金森平和.
Successful preemptive donor lymphocyte
Hirai M, Yagasaki H, Fujimura J, Inoue M,
infusions from a haploidentical donor in a
Leuk
31
Shimozawa K, Okuma H, Chin M,
boy with E2A-HLF-positive ALL.
Lymphoma
Takahashi S.
30

Prophylaxis and treatment withmycophenolate mofetil in children withgraft-versus-host disease undergoing32
allogeneic hematopoietic stem celltransplantation: a nationwide survey inJapan.

雑誌名

発行
年

刊・号・
頁

業績
番号

High probability of follow-up termination
33 among AYA survivors after allogeneic
hematopoietic cell transplantation.

Miyamura K, Yamashita T, Atsuta Y,
Ichinohe T, Kato K, Uchida N, Fukuda T,
Blood
Ohashi K, Ogawa H, Eto T, Inoue M,
Advances
Takahashi S, Mori T, Kanamori H, Yabe H,
Hama A, Okamoto S, Inamoto Y.

2019

3(3):397405.

U33

A consideration for efficient unrelated
34 hematopoietic stem cell source
acquisition-from an experience of Japan.

Nishiwaki S, Miyamura K, Kanda Y,
Takanashi M, Uchida N, Fukuda T,
Ikegame K, Ohashi K, Eto T, Ozawa Y,
Bone Marrow
2020
Shiratori S, Iwato K, Matsuoka KI, Hidaka TransplantM, Ichinohe T, Atsuta Y, Kodera Y,
Okamoto S.

55(3):657
-60.

U34

Retrospective analysis of children withhigh-risk acute myeloid leukemia who
underwent allogeneic hematopoietic stem
35
cell transplantation following complete
remission with initial induction
chemotherapy in the AML-05 clinical trial.

Hyakuna N, Hashii Y, Ishida H, Umeda K,
Takahashi Y, Nagasawa M, Yabe H,
Pediatr Blood
Nakazawa Y, Koh K, Goto H, Fujisaki H,
2019
CancerMatsumoto K, Kakuda H, Yano M, Tawa
A, Tomizawa D, Taga T, Adachi S, Kato K.

66(10):e2
7875.

U35

Kudo K, Maeda M, Suzuki N, Kanegane H,
Ohga S, Ishii E, Shioda Y, Imamura T,
Nationwide retrospective review of
Imashuku S, Tsunematsu Y, Endo M,
hematopoietic stem cell transplantation in Shimada A, Koga Y, Hashii Y, Noguchi M,
36
Int J Hematol 2020children with refractory Langerhans cell
Inoue M, Tabuchi K, Morimoto A;
histiocytosis.
Histiocytosis study group of theJapanese Society of PediatricHematology/Oncology.

111(1):13
7-48.

U36

A high CD34+ cell dose is associated with
better disease-free survival in patients
37 with low-risk diseases undergoing
peripheral blood stem cell transplantationfrom HLA-matched related donors.

55(9):172
6-35.

U37

論文タイトル

著者

Yokoyama Y, Maie K, Fukuda T, Uchida N,
Mukae J, Sawa M, Kubo K, Kurokawa M, Bone Marrow
2020
Nakamae H, Ichinohe T, Atsuta Y, Chiba Transplant
S.

Horio T, Morishita E, Mizuno S, Uchino K,
Donor Heme Oxygenase-1 Promoter Gene
Hanamura I, Espinoza JL, Morishima Y,
Polymorphism Predicts Survival after
38
Kodera Y, Onizuka M, Kashiwase K,
Cancers
Unrelated Bone Marrow Transplantation
Fukuda T, Doki N, Miyamura K, Mori T,
for High-Risk Patients.
Nakao S, Takami A.

2020

12(2):E42
4.

U38

Could the minimum number of
haematopoietic stem cells to obtain39
engraftment exist in unrelated, single cord
blood transplantation?

Yabe H, Tabuchi K, Uchida N, Takahashi
S, Onishi Y, Aotsuka N, Sugio Y, Ikegame Br J
K, Ichinohe T, Takahashi M, Kato K,
Haematol
Atsuta Y, Kanda Y.

2020

189(2):e5
6-60.

U39

Kaito S, Nakajima Y, Hara K, Toya T,
Heterogeneous impact of cytomegalovirus Nishida T, Uchida N, Mukae J, Fukuda T,
Blood
40 reactivation on nonrelapse mortality inOzawa Y, Tanaka M, Ikegame K,
Advances
hematopoietic stem cell transplantation.
Katayama Y, Kuriyama T, Kanda J, Atsuta
Y, Ogata M, Taguchi A, Ohashi K.

2020

4(6):1051
-61.

U40

Yachiyo Kuwatsuka ,Yoshiko Atsuta ,Akihiro Hirakawa ,Naoyuki Uchida ,Yoshihiro Inamoto ,Yuho Najima ,Kazuhiro Ikegame ,Tetsuya Eto , Yukiyasu Int J Hematol 2020
Ozawa ,Tatsuo Ichinohe , Masami Inoue,Takafumi Kimura , Shinichiro Okamoto ,Koichi Miyamura , Takahiro Fukuda.

112(6):84
1-50.

U41

59(16):19
47-56.

U42

41

Use of unapproved or off‑label drugs inJapan for the treatment of graft‑versus‑
host disease and post‑transplant viral
infection.

Makoto Murata, Ritsuro Suzuki , Tetsuya
Nishida , Shuichi Shirane , Yutaka
Allogeneic Hematopoietic Stem Cell
Shimazu ,Yosuke Minami, Takehiko Mori ,Transplantation for Post-essential
Noriko Doki, Yoshinobu Kanda, Naoyuki
42
Intern Med
Thrombocythemia and Post-polycythemia Uchida, Masatsugu Tanaka, Jun Ishikawa,Vera Myelofibrosis.
Kazuto Togitani, Takahiro Fukuda, Tatsuo
Ichinohe,Yoshiko Atsuta, Tokiko
Nagamura-Inoue,Hitoshi Kiyoi.

2020

論文タイトル

著者

雑誌名

発行
年

刊・号・
頁

業績
番号

Muramatsu H, Sakaguchi H, Taga T,
Tabuchi K, Adachi S, Inoue M, Kitoh T,
Suminoe A, Yabe H, Azuma E, Shioda Y, Pediatr Blood
2014
Ogawa A, Kinoshita A, Kigasawa H, Osugi Cancer
Y, Koike K, Kawa K, Kato K, Atsuta Y,
Kudo K.

61(5):925 WGP-7.
1-1

Comparison of a fludarabine and melphalan
combination-based reduced toxicity
Ishida H, Adachi S, Hasegawa D, Okamoto
conditioning with myeloablative
Y, Goto H, Inagaki J, Inoue M, Koh K,
Pediatr Blood44
2015
conditioning by radiation and/or busulfan in Yabe H, Kawa K, Kato K, Atsuta Y, Kudo Cancer
acute myeloid leukemia in JapaneseK.
children and adolescents.

62(5):883 WGP-9.
1-2

Comparison of Outcomes for PediatricPatients With Acute Myeloid Leukemia in
Remission and Undergoing Allogeneic
Hematopoietic Cell Transplantation With
45 Myeloablative Conditioning Regimens
Based on Either Intravenous Busulfan or
Total Body Irradiation: A Report From theJapanese Society for Hematopoietic Cell
Transplantation.

Ishida H, Kato M, Kudo K, Taga T,
Tomizawa D, Miyamura T, Goto H, Inagaki Biol Blood
J, Koh K, Terui K, Ogawa A, Kawano Y,
Marrow
Inoue M, Sawada A, Kato K, Atsuta Y,
Transplant
Yamashita T, Adachi S.

201521(12):21 WGP
41-7.
1-3

Role of Second Transplantation for
46 Children With Acute Myeloid Leukemia
Following Posttransplantation Relapse.

Taga T, Murakami Y, Tabuchi K, Adachi S,
Tomizawa D, Kojima Y, Kato K, Koike K, Pediatr Blood
2016
Koh K, Kajiwara R, Hamamoto K, Yabe H, Cancer
Kawa K, Atsuta Y, Kudo K.

63(4):701 WGP-5.
1-4

Reduced intensity conditioning in
43 allogeneic stem cell transplantation for
AML with Down syndrome.

Tomizawa D, Tanaka S, Kondo T, Hashii
Y, Arai Y, Kudo K, Taga T, Fukuda T,
Allogeneic Hematopoietic Stem Cell
Goto H, Inagaki J, Koh K, Ohashi K,
47 Transplantation for Adolescents and Young
Ozawa Y, Inoue M, Kato K,Tanaka J,
Adults with Acute Myeloid Leukemia.
Atsuta Y, Adachi S, Ishida H.

Biol Blood
Marrow
Transplant2017

23(9):151 WGP
5-22.
1-5

Allogeneic hematopoietic stem celltransplantation for children and
48 adolescents with high-risk cytogenetic
AML: distinctly poor outcomes of FUSERG-positive cases.

Tomizawa D, Yoshida M, Kondo T,
Miyamura T, Taga T, Adachi S, Koh K,
Noguchi M, Kakuda H, Watanabe K, Cho
Y, Fukuda T, Kato M, Shiba N, Goto H,
Okada K, Inoue M, Hashii Y, Atsuta Y,
Ishida H.

Bone Marrow
2019
Transplant54(3):393 WGP
-401.
1-6

Comparison of conditioning regimens forautologous stem cell transplantation in49
children with acute myeloid leukemia: A
nationwide retrospective study in Japan.

Sakaguchi H, Muramatsu H, Hasegawa D,
Kudo K, Ishida H, Yoshida N, Koh K,
Noguchi M, Shiba N, Tokimasa S, Fukuda
Pediatr Blood
T, Goto H, Miyamura T, Nakazawa Y,
2019
CancerHashii Y, Inoue M, Atsuta Y; Pediatric
AML Working Group of the Japan Societyfor Hematopoietic Cell Transplantation.

66(1):e27 WGP
459.
1-7

Okamoto Y, Kudo K, Tabuchi K, Tomizawa
Hematopoietic stem-cell transplantation in D, Taga T, Goto H, Yabe H, Nakazawa Y,
Bone Marrow
50 children with refractory acute myeloid
Koh K, Ikegame K, Yoshida N, Uchida N,
2019
Transplantleukemia.
Watanabe K, Koga Y, Inoue M, Kato K,
Atsuta Y, Ishida H.

54(9):148 WGP
9-98.
1-8

雑誌名

発行
年

刊・号・
頁

業績
番号

Miyamura T, Kudo K, Tabuchi K, Ishida H,
Hematopoietic stem cell transplantation for
Tomizawa D, Adachi S, Goto H, Yoshida
pediatric acute myeloid leukemia patients
51
N, Inoue M, Koh K, Sasahara Y, Fujita N, Leuk Res
with KMT2A rearrangement; A nationwide
Kakuda H, Noguchi M, Hiwatari M, Hashii
retrospective analysis in Japan.
Y, Kato K, Atsuta Y, Okamoto Y.

2019

87:10626
3.

WGP
1-9

論文タイトル著者

Yamamoto S, Tomizawa D, Kudo K,
Hematopoietic stem cell transplantation for
Hasegawa D, Taga T, Yanada M, Kondo T, Pediatr Blood
52 pediatric acute promyelocytic leukemia in
2020
Nakazawa Y, Eto T, Inoue M, Kato K,
CancerJapan.
Atsuta Y, Ishida H.

67(5):e28 WGP
181.
1-10

Donor lymphocyte infusion for thetreatment of relapsed acute myeloid
leukemia after allogeneic hematopoietic
stem cell transplantation: a retrospective
53
analysis by the Adult Acute Myeloid
Leukemia Working Group of the Japan
Society for Hematopoietic Cell
Transplantation.

Takami A, Yano S, Yokoyama H,
Kuwatsuka Y, Yamaguchi T, Kanda Y,
Morishima Y, Fukuda T, Miyazaki Y,
Nakamae H, Tanaka J, Atsuta Y,
Kanamori H.

Biol Blood
Marrow
Transplant2014

20(11):17 WGP
85-90.
2-1

Outcome of allogeneic hematopoietic stem Aoki J, Ishiyama K, Taniguchi S, Fukuda
Biol Bloodcell transplantation for acute myeloid
T, Ohashi K, Ogawa H, Kanamori H, Eto T,
Marrow
leukemia patients with central nervous
Iwato K, Sakamaki H, Morishima Y,
Transplantsystem involvement.
Nagamura T, Atsuta Y, Takami A.

2014

20(12):20 WGP
29-33.
2-2

2015

126(3):41 WGP
5-22.
2-3

Arai Y, Aoki K, Takeda J, Kondo T, Eto T,
Clinical significance of high-dose
Ota S, Hashimoto H, Fukuda T, Ozawa Y,
cytarabine added to
Kanda Y, Kato C, Kurokawa M, Iwato K,
J Hematol
56 cyclophosphamide/total-body irradiation in Onizuka M, Ichinohe T, Atsuta Y, Takami
Oncolbone marrow or peripheral blood stem cell A ; AML and MDS Working Group oftransplantation for myeloid malignancy.
Japan Society for Hematopoietic Cell
Transplantation.

2015

8:102.

Impact of age on outcomes of allogeneic
hematopoietic stem cell transplantation
57 with reduced intensity conditioning inelderly patients with acute myeloid
leukemia.

2016

91(3):302 WGP-7.
2-5

Bone Marrow
2016
Transplant51(4):604 WGP-6.
2-6

Comparable outcomes between autologous Mizutani M, Hara M, Fujita H, Aoki J,
Bone Marrow
59 and allogeneic transplant for adult acute
Kanamori H, Ohashi K, Usuki K, Fukuda T,
2016
Transplantmyeloid leukemia in first CR.
Chou T, Tanaka J, Atsuta Y, Takami A.

51(5):645 WGP
-53.
2-7

54

Efficiency of high-dose cytarabine added
55 to CY/TBI in cord blood transplantation
for myeloid malignancy.

Arai Y, Takeda J, Aoki K, Kondo T,
Takahashi S, Onishi Y, Ozawa Y, Aotsuka
N, Kouzai Y, Nakamae H, Ota S, Nakaseko
C, Yamaguchi H, Kato K, Atsuta Y,
Blood
Takami A ; AML and MDS Working Groupof the Japan Society for Hematopoietic
Cell Transplantation.

Aoki J, Kanamori H, Tanaka M, Yamasaki
S, Fukuda T, Ogawa H, Iwato K, Ohashi K,
Am J
Okumura H, Onizuka M, Maesako Y,
Hematol
Teshima T, Kobayashi N, Morishima Y,
Hirokawa M, Atsuta Y, Yano S, Takami A.

Impact of low-dose TBI on outcomes of
Aoki J, Seo S, Kanamori H, Tanaka M,
reduced intensity conditioning allogeneic
Fukuda T, Onizuka M, Kobayashi N,
58
hematopoietic stem cell transplantation for Kondo T, Sawa M, Uchida N, Iwato K,
AML.
Icihnohe T, Atsuta Y, Yano S, Takami A.

WGP
2-4

論文タイトル

著者

雑誌名

発行
年

Mori J, Ishiyama K, Yamaguchi T, Tanaka
Outcomes of allogeneic hematopoietic cell J, Uchida N, Kobayashi T, Fukuda T,
60 transplantation in patients withKanamori H, Miyamura K, Takahashi S,
Ann Hematol 2016biphenotypic acute leukemia.
Eto T, Hirokawa M, Mori S, Nagamura T,
Atsuta Y, Takami A.

刊・号・
頁

業績
番号

95(2):295 WGP
-300.
2-8

Acute megakaryoblastic leukemia, unlike
acute erythroid leukemia, predicts an
61
unfavorable outcome after allogeneic
HSCT.

Ishiyama K, Yamaguchi T, Eto T, Ohashi
K, Uchida N, Kanamori H, Fukuda T,
Miyamura K, Inoue Y, Taguchi J, Mori T, Leuk Res
Iwato K, Morishima Y, Nagamura-Inoue T,
Atsuta Y, Sakamaki H, Takami A.

Role of reduced-intensity conditioning
allogeneic hematopoietic cell
62
transplantation in older patients with denovo acute myeloid leukemia.

Yamasaki S, Hirakawa A, Aoki J, UchidaN, Fukuda T, Ogawa H, Ohashi K, Kondo
T, Eto T, Kanamori H, Okumura H, Iwato
K, Ichinohe T, Kanda J, Onizuka M,
Kuwatsuka Y, Yanada M, Atsuta Y,
Takami A, Yano S.

Ann Hematol 2017

96(2):289 WGP
-97.
2-10

Reduced-intensity conditioning allogeneic
hematopoietic cell transplantation for
63
younger patients with acute myeloid
leukemia: a registry-based study.

Yanada M, Kurosawa S, Kobayashi T,
Ozawa Y, Kanamori H, Kobayashi N, Sawa Bone Marrow
2017
M, Nakamae H, Uchida N, Hashimoto H,
Transplant
Fukuda T, Hirokawa M, Atsuta Y, Yano S.

52(6):818 WGP
-24.
2-11

Allogeneic Hematopoietic Cell
Transplantation for Leukemic
Transformation Preceded by Philadelphia
Chromosome-Negative Myeloproliferative64
Neoplasms: A Nationwide Survey by the
Adult Acute Myeloid Leukemia Working
Group of the Japan Society for
Hematopoietic Cell Transplantation.

Takagi S, Masuoka K, Uchida N, Kurokawa Biol Blood
M, Nakamae H, Imada K, Iwato K, Ichinohe Marrow
T, Atsuta Y, Takami A, Yano S.
Transplant2016

22(12):22 WGP
08-13.
2-12

Konuma T, Kondo T, Yamashita T, UchidaN, Fukuda T, Ozawa Y, Ohashi K, Ogawa
Outcome of allogeneic hematopoietic stem H, Kato C, Takahashi S, Kanamori H, Eto
cell transplantation in adult patients with T, Nakaseko C, Kohno A, Ichinohe T,
65
Ann Hematol 2017
acute myeloid leukemia harboring trisomy Atsuta Y, Takami A, Yano S; Adult Acute
8.
Myeloid Leukemia Working Group of theJapan Society for Hematopoietic Cell
Transplantation (JSHCT).

96(3):469 WGP
-78.
2-13

Yanada M, Yano S, Kanamori H, Gotoh M,
Autologous hematopoietic cell
Emi N, Watakabe K, Kurokawa M,
transplantation for acute promyelocytic
Nishikawa A, Mori T, Tomita N, Murata M, Leuk
66 leukemia in second complete remission:
Hashimoto H, Henzan H, Kanda Y, Sawa Lymphoma
outcomes before and after the introduction
M, Kohno A, Atsuta Y, Ichinohe T, Takami
of arsenic trioxide.
A.

2017

58(5):106 WGP
1-7.
2-14

Outcomes of Allogeneic Hematopoietic
Cell Transplantation in Acute Myeloid
67
Leukemia Patients with Abnormalities of
the Short Arm of Chromosome 17.

201723(8):139 WGP
8-404.
2-15

Mori J, Yanada M, Uchida N, Fukuda T,
Sakura T, Hidaka M, Watakabe-Inamoto
K, Kanamori H, Ogawa H, Ichinohe T,
Tanaka J, Atsuta Y, Yano S.

Biol Blood
Marrow
Transplant2016

47:47-53.

WGP
2-9

雑誌名

発行
年

刊・号・
頁

Effect of cytogenetic risk status on
outcomes for patients with acute myeloid
leukemia undergoing various types of68
allogeneic hematopoietic celltransplantation: an analysis of 7812
patients.

Yanada M, Mori J, Aoki J, Harada K,
Mizuno S, Uchida N, Kurosawa S, Toya T,
Leuk
Kanamori H, Ozawa Y, Ogawa H, Henzan
Lymphoma
H, Iwato K, Sakura T, Ota S, Fukuda T,
Ichinohe T, Atsuta Y, Yano S.

201859(3):601 WGP
-9.
2-16

Outcomes after allogeneic hematopoietic
stem cell transplantation in patients with69
acute myeloid leukemia harboringt(7;11)(p15;p15).

Harada K, Doki N, Aoki J, Mori J, Machida
S, Masuko M, Uchida N, Najima Y, Fukuda
Haematologic
T, Kanamori H, Ogawa H, Ota S, Ogawa K,
2018aTakahashi S, Kasai M, Maeda A, Nagafuji
K, Kawakita T, Ichinohe T, Atsuta Y.

103(2):e6 WGP
9-72.
2-17

Comparison of Autologous and Unrelated
70 Transplants for Cytogenetically Normal
Acute Myelogenous Leukemia.

Mizutani M, Takami A, Hara M, Mizuno S,
Yanada M, Chou T, Uchiyama H, Ohashi
Biol Blood
K, Miyamoto T, Ozawa Y, Imataki O,
Marrow
Kobayashi N, Uchida N, Kanamori H,
Transplant
Kamimura T, Eto T, Onizuka M, Tanaka J,
Atsuta Y, Yano S.

201723(9):144 WGP
7-54.
2-18

Allogeneic haematopoietic celltransplantation for adult acute myeloid
leukaemia in second remission: a
71 retrospective study of the Adult Acute
Myeloid Leukaemia Working Group of theJapan Society for Haematopoietic Cell
Transplantation (JSHCT).

Konuma T, Yanada M, Yamasaki S,
Kuwatsuka Y, Fukuda T, Kobayashi T,
Br J
Ozawa Y, Uchida N, Ota S, Hoshino T,
Haematol
Takahashi S, Kanda Y, Ueda Y, Takanashi
M, Kanda J, Ichinohe T, Atsuta Y, Yano S.

2018

182(2):24 WGP
5-50.
2-19

Konuma T, Mizuno S, Kondo T,
Yamaguchi H, Fukuda T, Uchida N, Najima
Y, Kanamori H, Ota S, Nakamae H,
Nakamae M, Mizuno I, Sugita J, Onishi Y,
Yokota A, Takahashi S, Kanda Y, Ichinohe Ann Hematol 2018
T, Atsuta Y, Yano S; Adult Acute Myeloid
Leukemia Working Group of the Japan
Society for Hematopoietic Cell
Transplantation (JSHCT).

97(11):21 WGP
73-83.
2-20

Patients with acute myeloid leukemia
undergoing allogeneic hematopoietic cell73
transplantation: trends in survival during
the past two decades.

Yanada M,Masuko M,Mori J,Aoki J,Mizuno
S,Fukuda T,Kakihana K,Ozawa Y,ota
Bone Marrow
S,Kannamori H,Mori T,Nakamae H,Eto
2019
TransplantT,Shiratori S,Maeda T,Iwato K,Ichinohe
T,Kanda Y,Tanaka J,Atsuta Y,Yano S.

54(4):578 WGP
-86
2-21

Prognostic impact of melphalan dose andtotal body irradiation use in patients with
74 acute myeloid leukemia undergoing
allogeneic stem cell transplantation with
reduced-intensity conditioning.

Harada K, Yanada M, Machida S,
Kanamori H, Onizuka M, Ozawa Y,
Leuk
Kobayashi H, Sawa M, Katayama Y,
Lymphoma
Ohashi K, Kanda J, Ichinohe T, Atsuta Y,
Yano S.

201960(6):149 WGP
3-502
2-22

Hematopoietic Cell Transplantation for
75 Acute Panmyelosis with Myelofibrosis: A
Retrospective Study in Japan.

Konuma T, Kondo T, Kawata T, Iwato K3,
Sato Y, Mori T, Ohashi K, Nakazawa H,
Sugahara H, Ago H, Eto T, Imamura Y,
Biol Blood
Fukuda T, Kanda Y, Atsuta Y, Yano S;
Marrow
Adult Acute Myeloid Leukemia Working
TransplantGroup of the Japan Society for
Hematopoietic Cell Transplantation.

2019

25(1):e23 WGP
-7.
2-23

論文タイトル

Allogeneic hematopoietic celltransplantation in adult acute myeloid
leukemia with 11q23 abnormality: aretrospective study of the Adult Acute72
Myeloid Leukemia Working Group of theJapan Society for Hematopoietic Cell
Transplantation (JSHCT).

著者

業績
番号

論文タイトル

著者

雑誌名

Konuma T, Harada K, Yamasaki S, Mizuno
Upfront allogeneic hematopoietic cell
S, Uchida N, Takahashi S, Onizuka M,
transplantation (HCT) versus remission
Nakamae H, Hidaka M, Fukuda T, Ohashi
induction chemotherapy followed byK, Kohno A, Matsushita A, Kanamori H,
Am J
76
allogeneic HCT for acute myeloid leukemia Ashida T, Kanda J, Atsuta Y, Yano S;
Hematolwith multilineage dysplasia: A propensity
Adult Acute Myeloid Leukemia Working
score matched analysis.
Group of the Japan Society for
Hematopoietic Cell Transplantation.

発行
年

刊・号・
頁

2019

94(1):103 WGP
-10.
2-24

2019

8(2):509.

Effect of allogeneic stem cell
77 transplantation in patients with minimallydifferentiated acute myeloid leukemia.

Yamasaki S, Aoki J,Mori J, Harada K,
Sawa M, Uchida M, Ohashi K, Fukuda T, 日本造血細Koh S, Kanamori H, Ogawa H, Okumura H, 胞移植学会
Ichinohe T, Kanda Y, Tanaka J, Atsuta Y, 雑誌
Yanada M, Yano S.

Unit selection for umbilical cord bloodtransplantation for adults with acute78
myeloid leukemia in complete remission: aJapanese experience.

Yanada M, Konuma T, Kuwatsuka Y,
Kondo T, Kawata T, Takahashi S, Uchida
Bone Marrow
N, Miyakoshi S, Tanaka M, Ozawa Y,
2019Transplant
Sawa M, Nakamae H, Aotsuka N, Kanda ,Takanashi M, Kanda Y, Atsuta Y, Yano S.

Risk stratification and prognosticators of
acute myeloid leukemia with
Harada K, Konuma T, Machida S, Mori J,
myelodysplasia-related changes patients
Aoki J, Uchida N, Ohashi K, Fukuda T,
Biol Blood
undergoing allogeneic stem cell79
Tanaka M, Ikegame K, Ozawa Y, Iwato K, Marrowtransplantation: a retrospective study of
Eto T, Onizuka M, Ichinohe T, Atsuta Y, Transplant
the Adult Acute Myeloid Leukemia Working
Yano S.
Group of the Japan Society for
Hematopoietic Cell Transplantation.

業績
番号

WGP
2-25

54(11):17 WGP
89-98.
2-26

201925(9):173 WGP
0-43.
2-27

Role of alternative donor allogeneic
hematopoietic stem cell transplantation in
80 patients with intermediate- or poor-risk
acute myeloid leukemia in first complete
remission.

Yano S, Yokoyama H, Yanada M, Mori J,
Aoki J, Ohashi K, Kanomori H, Ozawa Y, Bone Marrow
2019
Sawa M, Nakamae H, Eto T, Ohta S,
Transplant
Tanaka J, Ichinohe T, Atsuta Y, Takami A.

54(12):20 WGP
04-12.
2-28

Better disease control before allogeneic
stem cell transplantation is crucial to
81 improve the outcomes of transplantation
for acute myeloid leukemia patients withextramedullary disease.

Yamasaki S, Aoki J, Mori J, Mizuno S,
Uchida N, Ohashi K, Fukuda T, Ikegame K,
Eto T, Ogawa Y, Tanaka M, Hidaka M,
Iwato K, Sawa M, Ichinohe T, Kanda Y,
Bone Marrow
2020
Atsuta Y, Yanada M, Yano S; Adult Acute Transplant
Myeloid Leukemia Working Group of theJapan Society for Hematopoietic Cell
Transplantation.

55(1):249 WGP
-52.
2-29

Yanada M , Konuma T , Yamasaki S ,Time-Varying Effects of Graft Type on
Kuwatsuka Y , Masuko M , Tanaka M ,Biol Blood
Outcomes for Patients with Acute Myeloid Ozawa Y , Toya T , Fukuda T , Ota S ,82
Marrow
Leukemia Undergoing Allogeneic
Sawa M , Uchida N , Nakamae H , Eto T ,Transplant
Hematopoietic Cell Transplantation.
Kanda J , Takanashi M , Kanda Y , Atsuta
Y , Yano S.

2020

26(2):307 WGP
-15.
2-30

Yanada M, Mori J, Aoki J, Masuko M,
Harada K, Uchida N, Doki N, Fukuda T,
Sakura T, Kanamori H, Sawa M, Kondo T, Ann Hematol 2019
Katayama Y, Kanda J, Ichinohe T, Atsuta
Y, Yano S.

98(9):217 WGP
9-86.
2-31

Yanada M, Takami A, Mizuno S, Mori J,
Autologous hematopoietic cell
Chou T, Usuki K, Uchiyama H, Amano I,
84 transplantation for acute myeloid leukemia Fujii S, Miyamoto T, Saito T, Kamimura T, Int J Hematol 2020
in adults: 25 years of experience in Japan. Ichinohe T, Fukuda T, Okamoto S, Atsuta
Y, Yano S.

111(1):93 WGP
-102.
2-32

Allogeneic hematopoietic celltransplantation for patients with a history83of multiple relapses of acute myeloid
leukemia.

雑誌名

発行
年

刊・号・
頁

Conditioning Intensity for Allogeneic
Hematopoietic Cell Transplantation in
85 Acute Myeloid Leukemia Patients with
Poor-Prognosis Cytogenetics in First
Complete Remission.

Konuma T, Kondo T, Mizuno S, Doki N,
Aoki J, Fukuda T, Tanaka M, Sawa M,
Katayama Y, Uchida N, Ozawa Y,
Biol Blood
Morishige S, Matsuoka KI, Ichinohe T,
Marrow
Onizuka M, Kanda J, Atsuta Y, Yanada M;
Transplant
Adult Acute Myeloid Leukemia Working
Group of the Japan Society for
Hematopoietic Cell Transplantation.

2020

26(3):463 WGP
-71.
2-33

Long-term results of reduced-intensity
conditioning allogeneic hematopoietic cell
86 transplantation for older patients withacute myeloid leukemia: a retrospective
analysis of 10-year follow-up data.

Yanada M, Fukuda T, Tanaka M, Ota S,
Toya T, Mori T, Uchida N, Ozawa Y,
Nakamae H, Kanda Y, Ichinohe T, Atsuta
Y, Yano S.

Bone Marrow
2020
Transplant55(10):20 WGP
08-16.
2-34

Allogeneic hematopoietic celltransplantation for adults with acute87
myeloid leukemia conducted in Japan
during the past quarter century.

Yanada M, Takami A, Yamasaki S, Arai Y,
Konuma T, Uchida N, Najima Y, Fukuda T,
Tanaka M, Ozawa Y, Ikegame K,
Ann Hematol 2020
Takanashi M, Ichinohe T, Okamoto S,
Atsuta Y, Yano S.

99(6):135 WGP
1-60.
2-35

Allogeneic hematopoietic celltransplantation efficacy in patients with
88
Philadelphia chromosome-positive acute
myeloid leukemia in complete remission.

Shohei Mizuno , Masamitsu Yanada , Koji
Kawamura , Masayoshi Masuko , Naoyuki
Uchida , Yukiyasu Ozawa , Koji Iwato ,Kazuteru Ohashi , Kazuhiro Ikegame ,Bone Marrow2021
Sung-Won Kim , Masatsugu Tanaka ,Transplant
Tetsuya Eto , Yoshinobu Kanda , Takahiro
Fukuda , Yoshiko Atsuta , Shingo Yano ,Akiyoshi Takami.

56(1):232 WGP
-42.
2-36

Predicting non-relapse mortality following
allogeneic hematopoietic cell89
transplantation during first remission of
acute myeloid leukemia.

Masamitsu Yanada , Takaaki Konuma ,Shohei Mizuno , Masuho Saburi , Akihito
Shinohara , Masatsugu Tanaka , Atsushi
Marumo , Masashi Sawa , Naoyuki Uchida
Bone Marrow, Yukiyasu Ozawa , Makoto Onizuka ,2021
Transplant
Satoshi Yoshioka , Hirohisa Nakamae ,Tadakazu Kondo , Takafumi Kimura ,Junya Kanda , Takahiro Fukuda , Yoshiko
Atsuta , Hideki Nakasone , Shingo Yano.

56(2):387 WGP
-94.
2-37

Satoshi Yamasaki , Jinichi Mori , Junya
Kanda , Nobuhiko Imahashi , Naoyuki
Effect of allogeneic HCT from unrelated
Uchida , Noriko Doki , Masatsugu Tanaka
donors in AML patients with intermediate- , Yuta Katayama , Tetsuya Eto , Yukiyasu
90
Ann Hematol 2020
or poor-risk cytogenetics: a retrospective Ozawa , Satoru Takada , Makoto Onizuka
study from the Japanese Society for HCT. , Masayuki Hino , Yoshinobu Kanda ,Takahiro Fukuda , Yoshiko Atsuta ,Masamitsu Yanada.

99(12):29 WGP
27-37.
2-38

論文タイトル

著者

業績
番号

Relapse of acute myeloid leukemia after
allogeneic hematopoietic cell91
transplantation: clinical features andoutcomes.

Masamitsu Yanada , Takaaki Konuma ,Satoshi Yamasaki , Tadakazu Kondo ,Takahiro Fukuda , Naoki Shingai , Masashi
Sawa , Yukiyasu Ozawa , Masatsugu
Bone Marrow
Tanaka , Naoyuki Uchida , Hirohisa
Transplant
Nakamae , Yuta Katayama , Ken-Ichi
Matsuoka , Takafumi Kimura , Yoshinobu
Kanda , Tatsuo Ichinohe , Yoshiko Atsuta, Shingo Yano.

in press

Second allogeneic hematopoietic SCT for
92
relapsed ALL in children.

Kato M, Horikoshi Y, Okamoto Y,
Takahashi Y, Hasegawa D, Koh K, Takita
Bone Marrow
J, Inoue M, Kigasawa H, Ogawa A,
2012
Transplant
Sasahara Y, Kawa K, Yabe H, Sakamaki H,
Suzuki R, Kato K.

47(10):13 WGP
07-11.
3-1

WGP
2-39

著者

雑誌名

発行
年

刊・号・
頁

Kato M, Takahashi Y, Tomizawa D,
Okamoto Y, Inagaki J, Koh K, Ogawa A,
Okada K, Cho Y, Takita J, Goto H,
Sakamaki H, Yabe H, Kawa K, Suzuki R,
Kudo K, Kato K.

Biol Blood
Marrow
Transplant2013

19(12):16 WGP
90-4.
3-2

2015

125(8):13 WGP
52-4.
3-3

Goto H, Kaneko T, Shioda Y, Kajiwara M,
Hematopoietic stem cell transplantation for
Sakashita K, Kitoh T, Hayakawa A, Miki M, Pediatr Blood
95 patients with acute lymphoblastic leukemia
2015
Kato K, Ogawa A, Hashii Y, Inukai T, Kato Cancer
and Down syndrome.
C, Sakamaki H, Yabe H, Suzuki R, Kato K.

62(1):148 WGP
-52.
3-4

Allogeneic haematopoietic stem celltransplantation for infant acutelymphoblastic leukaemia with KMT2A
Kato M, Hasegawa D, Koh K, Kato K,(MLL) rearrangements: a retrospective
Takita J, Inagaki J, Yabe H, Goto H,
96
study from the paediatric acute
Adachi S, Hayakawa A, Takeshita Y,
lymphoblastic leukaemia working group of Sawada A, Atsuta Y, Kato K.
the Japan Society for Haematopoietic Cell
Transplantation.

Br J
Haematol

2015

168(4):56 WGP
4-70.
3-5

Comparison of chemotherapeutic agentsas a myeloablative conditioning with total
body irradiation for pediatric acute97 lymphoblastic leukemia: A study from thepediatric ALL working group of the Japan
Society for Hematopoietic Cell
Transplantation.

Kato M, Ishida H, Koh K, Inagaki J, Kato
K, Goto H, Kaneko T, Cho Y, Hashii Y,
Kurosawa H, Takita J, Hamamoto K,
Inoue M, Sawada A, Suzuki R, Kato K.

Pediatr Blood
2015
Cancer62(10):18 WGP
44-50.
3-6

Impact of graft-versus-host disease on
98 relapse and survival after allogeneic stem
cell transplantation for pediatric leukemia.

Kato M, Kurata M, Kanda J, Kato K,
Tomizawa D, Kudo K, Yoshida N,
Watanabe K, Shimada H, Inagaki J, Koh K, Bone Marrow
2019
Goto H, Kato K, Cho Y, Yuza Y, Ogawa A, Transplant
Okada K, Inoue M, Hashii Y, Teshima T,
Murata M, Atsuta Y.

54(1):68- WGP
75.
3-7

Allogeneic Stem Cell Transplantation for
99 Acute Lymphoblastic Leukemia in
Adolescents and Young Adults.

Hangai M, Urayama KY, Tanaka J, Kato K,
Biol Blood
Nishiwaki S, Koh K, Noguchi M, Kato K,
Marrow
Yoshida N, Sato M, Goto H, Yuza Y,
Transplant
Hashii Y, Atsuta Y, Mizuta S, Kato M.

25(8):159 WGP
7-602.
3-8

論文タイトルComparison of intravenous with oral
busulfan in allogeneic hematopoietic stem
93 cell transplantation with myeloablative
conditioning regimens for pediatric acuteleukemia.

Kato K, Kato M, Hasegawa D, Kawasaki H,
Comparison of transplantation with
Ishida H, Okamoto Y, Koh K, Inoue M,
94 reduced and myeloablative conditioning for
Blood
Inagaki J, Kato K, Sakamaki H, Yabe H,
children with acute lymphoblastic leukemia.
Kawa K, Suzuki R, Atsuta Y.

2019

Yuta Kawahara , Akira Morimoto , Jiro
Inagaki , Katsuyoshi Koh , Maiko Noguchi ,Unrelated cord blood transplantation with Hiroaki Goto , Nao Yoshida , Yuko Cho ,myeloablative conditioning for pediatricTsukasa Hori , Mitsuteru Hiwatari ,Bone Marrow100
2021
acute lymphoblastic leukemia in remission: Keisuke Kato , Atsushi Ogawa , Yoshiko Transplant
prognostic factors.
Hashii , Masami Inoue , Koji Kato ,Yoshiko Atsuta , Fumihiko Kimura ,Motohiro Kato.
Bone Marrow 2013
Reduced-intensity allogeneic stem cell
Kanamori H, Mizuta S, Kako S, Kato H,
Transplanttransplantation for patients aged 50 years Nishiwaki S, Imai K, Shigematsu A,or older with B-cell ALL in remission: aNakamae H, Tanaka M, Ikegame K, Yujiri
101
retrospective study by the Adult ALL
T, Fukuda T, Minagawa K, Eto T,
Working Group of the Japan Society for
Nagamura-Inoue T, Morishima Y, Suzuki
Hematopoietic Cell Transplantation.
R, Sakamaki H, Tanaka J.
Nishiwaki S, Miyamura K, Ohashi K,
Impact of a donor source on adult
Kurokawa M, Taniguchi S, Fukuda T,
Philadelphia chromosome-negative acute
Ikegame K, Takahashi S, Mori T, Imai K,
lymphoblastic leukemia: a retrospective
Iida H, Hidaka M, Sakamaki H, Morishima
102 analysis from the Adult Acute
Y, Kato K, Suzuki R, Tanaka J; Adult
Lymphoblastic Leukemia Working Group of
Acute Lymphoblastic Leukemia Working
the Japan Society for Hematopoietic Cell
Group of the Japan Society forTransplantation.
Hematopoietic Cell Transplantation.

Ann Oncol

2013

業績
番号

56(2):357 WGP
-67.
3-9

48(12):15
13-8.
WGP
4-1

24(6):159
4-602.
WGP
4-2

論文タイトル
Reduced-intensity vs myeloablative
conditioning allogeneic hematopoietic SCT
for patients aged over 45 years with ALL
103 in remission: a study from the Adult ALL
Working Group of the Japan Society for
Hematopoietic Cell Transplantation(JSHCT).

著者
Tanaka J, Kanamori H, Nishiwaki S,
Ohashi K, Taniguchi S, Eto T, Nakamae H,
Minagawa K, Miyamura K, Sakamaki H,
Morishima Y, Kato K, Suzuki R, Nishimoto
N, Oba K, Masauzi N.

Kato H, Kawase T, Kako S, Mizuta S,
Kurokawa M, Mori T, Ohashi K, Iwato K,
Analysis of outcomes following autologous
Miyamura K, Hidaka M, Sakamaki H,
stem-cell transplantation in adult patientsSuzuki R, Morishima Y, Tanaka J; Adult
104 with Philadelphia chromosome-negative
Acute Lymphoblastic Leukemia Working
acute lymphoblastic leukemia during theGroup of Japan Society forfirst complete remission.
Hematopoietic Cell Transplantation(JSHCT).

発行 刊・号・
年
頁
Bone Marrow 2013 48(11):13
Transplant
89-94.
雑誌名

WGP
4-3

Haematologic 2014a

Int J Hematol 2017
Shigematsu A, Kako S, Mitsuhashi K,
Iwato K, Uchida N, Kanda Y, Fukuda T,
Sawa M, Senoo Y, Ogawa H, Miyamura K,
Takada S, Nagamura-Inoue T, Morishima
Y, Ichinohe T, Atsuta Y, Mizuta S, Tanaka
J.

Arai Y, Kondo T, Shigematsu A, Tanaka J, Am J
Ohashi K, Fukuda T, Hidaka M, Kobayashi Hematol
Improved prognosis with additionalN, Iwato K, Sakura T, Onizuka M, Ozawa
medium-dose VP16 to CY/TBI in
111
Y, Eto T, Kurokawa M, Kahata K, Uchidaallogeneic transplantation for high risk ALL
N, Atsuta Y, Mizuta S, Kako S.
in adults.

99(11):e228-30.
WGP
4-4

2014
Mizuta S, Matsuo K, Nishiwaki S, Imai K, Blood
Pretransplant administration of imatinib for Kanamori H, Ohashi K, Fukuda T, Onishi
105 allo-HSCT in patients with BCR-ABLY, Miyamura K, Takahashi S, Onizuka M,
positive acute lymphoblastic leukemia.
Atsuta Y, Suzuki R, Morishima Y, Kato K,
Sakamaki H, Tanaka J.
Nishiwaki S, Imai K, Mizuta S, Kanamori H, Bone Marrow 2016
Impact of MRD and TKI on allogeneic
Ohashi K, Fukuda T, Onishi Y, Takahashi Transplant
hematopoietic cell transplantation for
106
S, Uchida N, Eto T, Nakamae H, Yujiri T,
Ph+ALL: a study from the adult ALL WG of
Mori S, Nagamura-Inoue T, Suzuki R,
the JSHCT.
Atsuta Y, Tanaka J.
Biol Blood
2016
Mitsuhashi K, Kako S, Shigematsu A,
Comparison of Cyclophosphamide
Atsuta Y, Doki N, Fukuda T, Kanamori H, Marrow
Transplant
Combined with Total Body Irradiation, Oral Onizuka M, Takahashi S, Ozawa Y,
Busulfan, or Intravenous Busulfan for
Kurokawa M, Inoue Y, Nagamura-Inoue T,
107
Allogeneic Hematopoietic Cell
Morishima Y, Mizuta S, Tanaka J; Adult
Transplantation in Adults with Acute
Acute Lymphoblastic Leukemia Working
Lymphoblastic Leukemia.
Group of the Japan Society for
Hematopoietic Cell Transplantation.
High-dose cytarabine added to CY/TBI
Arai Y, Kondo T, Shigematsu A, Tanaka J, Bone Marrow 2016
Transplant
improves the prognosis of cord blood
Takahashi S, Kobayashi T, Uchida N,
108 transplantation for acute lymphoblastic
Onishi Y, Ishikawa J, Kanamori H, Sawa
leukemia in adults: a retrospective cohort M, Yokota A, Kouzai Y, Takanashi M,
study.
Ichinohe T, Atsuta Y, Mizuta S.
2017
Arai Y, Kondo T, Shigematsu A, Tanaka J, Br J
Ohashi K, Fukuda T, Kawakita T, Mori T, Haematol
Increased non-relapse mortality due to
Hoshino T, Onizuka M, Ozawa Y, Yoshidahigh-dose cytarabine plus CY/TBI in
109
S, Ueda Y, Mizuno I, Atsuta Y, Mizuta S;
BMT/PBSCT for acute lymphoblastic
Japan Society for Haematopoietic Cellleukaemia in adults.
Transplantation.
Allogeneic stem cell transplantation for
adult patients with acute lymphoblastic
leukemia who had central nervous system
110
involvement: a study from the Adult ALL
Working Group of the Japan Society for
Hematopoietic Cell Transplantation.

業績
番号

2018

123(15):2
325-32.

51(1):4350.

WGP
4-5

WGP
4-6

22(12):21
94-200.
WGP
4-751(12):16
36-9.

WGP
4-8

178(1):10
6-11.
WGP
4-9

105(6):80
5-11.
WGP
4-10

93(1):4757.
WGP
4-11

論文タイトル

著者

雑誌名

Akahoshi Y, Mizuta S, Shimizu H, Uchida Biol Blood
MarrowN, Fukuda T, Kanamori H, Onizuka M,
Additional Cytogenetic Abnormalities withTransplantOzawa Y, Ohashi K, Ohta S, Eto T,
Philadelphia Chromosome-Positive Acute
Tanaka J, Atsuta Y, Kako S; Adult Acute
112 Lymphoblastic Leukemia on Allogeneic
Lymphoblastic Leukemia Working Group
Stem Cell Transplantation in the Tyrosineof the Japan Society for Hematopoietic
Kinase Inhibitor Era.
Cell Transplantation.

発行 刊・号・年頁
2018 24(10):20
09-16.

2019
Akahoshi Y, Nishiwaki S, Mizuta S, Ohashi Cancer Sci
K, Uchida N, Tanaka M, Fukuda T, Ozawa
Y, Takahashi S, Onizuka M, Shiratori S,
Nakamae H, Kanda Y, Ichinohe T, Atsuta
Y, Kako S.
2019
Nishiwaki S, Mizuta S, Ohashi K, Fukuda Am J
HematolT, Uchida N, Tachibana T, Onizuka M,
Different impact of BCR-ABL transcripts
Ozawa Y, Onishi Y, Takahashi S, Eto T,
on allogeneic hematopoietic cell
Nakamae H, Tanaka J, Ichinohe T, Atsuta
114 transplantation from different graft
Y, Kako S; Adult Acute Lymphoblastic
sources for Ph + ALL with minimal residual
Leukemia Working Group of the Japandisease.
Society for Hematopoietic Cell
Transplantation.
Leuk
2019
The effect of melphalan dose and total
Harada K, Tachibana T, Ohashi K, Ozawa Lymphoma
body irradiation as reduced-intensity
Y, Sawa M, Kondo T, Ishikawa J, Onizuka
115 conditioning for acute lymphoblastic
M, Imada K, Fujisaki T, Tanaka J, Fukuda
leukemia patients undergoing allogeneic
T, Atsuta Y, Kako S.
stem cell transplantation.
Bone Marrow 2020
Kaito S, Najima Y, Harada K, Fukuda T,
Allogeneic hematopoietic stem cell
Noguchi Y, Ikegame K, Tanaka M, Ozawa Transplanttransplantation for adult patients with B- Y, Yoshida S, Sawa M, Ota S, Inoue Y,
116 cell acute lymphoblastic leukemia harboring Tanaka J, Ichinohe T, Atsuta Y, Kako S;t(1;19)(q23;p13.3); comparison with normal Adult Acute Lymphoblastic Leukemia
karyotype.
Working Group of the Japan Society for
Hematopoietic Cell Transplantation.
2020
Akahoshi Y, Igarashi A, Fukuda T, Uchida Br J
Impact of graft-versus-host disease andN, Tanaka M, Ozawa Y, Kanda Y, Onizuka Haematol
graft-versus-leukemia effect based on
M, Ichinohe T, Tanaka J, Atsuta Y, Kako
117 minimal residual disease in Philadelphia
S; Adult Acute Lymphoblastic Leukemia
chromosome-positive acute lymphoblastic
Working Group of the Japan Society forleukemia.
Hematopoietic Cell Transplantation.
Bone Marrow 2020
Reduced-intensity Conditioning Is a
Yu Akahoshi, Satoshi Nishiwaki, Yasuyuki Transplant
Reasonable Alternative for Philadelphia
Arai, Kaito Harada, Yuho Najima,
Chromosome-Positive AcuteYoshinobu Kanda, Katsuhiro Shono,
Lymphoblastic Leukemia Among Elderly
118
Shuichi Ota, Takahiro Fukuda, Naoyuki
Patients Who Have Achieved Negative
Uchida, Souichi Shiratori, Masatsugu
Minimal Residual Disease: A Report From
Tanaka, Junji Tanaka, Yoshiko Atsuta,
the Adult Acute Lymphoblastic Leukemia
Shinichi Kako.
Working Group of the JSHCT.
Ann Hematol 2020
Takayoshi Tachibana , Yuho Najima , Yu
Akahoshi , Shigeki Hirabayashi , Kaito
Harada , Noriko Doki , Naoyuki Uchida ,The impacts of BCR-ABL1 mutations in
Takahiro Fukuda , Masashi Sawa , Masao
patients with Philadelphia chromosomeOgata , Satoru Takada , Masatsugu
119 positive acute lymphoblastic leukemia who Tanaka , Yoshiko Matsuhashi , Junji
underwent allogeneic hematopoietic cell
Tanaka , Makoto Onizuka , Tatsuo
transplantation.
Ichinohe , Yoshiko Atsuta , Shinichi Kako
, Adult ALL Working Group of the Japan
Society for Hematopoietic Cell
Transplantation.
Tyrosine kinase inhibitor prophylaxis after
113 transplant for Philadelphia chromosomepositive acute lymphoblastic leukemia.

業績
番号

WGP
4-12

110(10):3
255-66.

WGP
4-13

94(11):E3
01-5.
WGP
4-14

60(14):35
21-8.

WGP
4-15

55(7):133
7-46.
WGP
4-16

190(1):84
-92.
WGP
4-17

55(7):131
7-25.
WGP
4-18

99(10):23
93-404.

WGP
4-19

論文タイトル

Measurable residual disease affects
allogeneic hematopoietic cell120
transplantation in Ph+ ALL during both
CR1 and CR2.

著者
Satoshi Nishiwaki, Yu Akahoshi, Shuichi
Mizuta, Akihito Shinohara, Shigeki
Hirabayashi, Yuma Noguchi, Takahiro
Fukuda, Naoyuki Uchida, Masatsugu
Tanaka, Makoto Onizuka, Yukiyasu
Ozawa, Shuichi Ota, Souichi Shiratori,
Yasushi Onishi, Yoshinobu Kanda,
Masashi Sawa, Junji Tanaka, Yoshiko
Atsuta, Shinichi Kako.

Yu Akahoshi, Yasuyuki Arai, Satoshi
Minimal residual disease (MRD) positivity
Nishiwaki, Shuichi Mizuta, Atsushi
at allogeneic hematopoietic cell
Marumo, Naoyuki Uchida, Yoshinobu
transplantation, not the quantity of MRD, is
121
Kanda, Hitoshi Sakai, Satoru Takada,a risk factor for relapse of Philadelphia
Takahiro Fukuda, Shin Fujisawa, Takashi
chromosome-positive acute lymphoblastic
Ashida, Junji Tanaka, Yoshiko Atsuta,
leukemia.
Shinichi Kako.
Effect of graft sources on allogeneic
hematopoietic stem cell transplantation
outcome in adults with chronic myeloid
122 leukemia in the era of tyrosine kinase
inhibitors: a Japanese Society of
Hematopoietic Cell Transplantation
retrospective analysis.
Clinical impact of pretransplant use ofmultiple tyrosine kinase inhibitors on the
123 outcome of allogeneic hematopoietic stem
cell transplantation for chronic
myelogenous leukemia.

雑誌名
Blood
Advances

発行 刊・号・
年
頁
2021 5(2):58492.

WGP
4-20

Int J Hematol

in press
WGP
4-21

Ohashi K, Nagamura-Inoue T, Nagamura
F, Tojo A, Miyamura K, Mori T, Kurokawa
Int J Hematol 2014
M, Taniguchi S, Ishikawa J, Morishima Y,
Atsuta Y, Sakamaki H.
Kondo T, Nagamura-Inoue T, Tojo A,
Nagamura F, Uchida N, Nakamae H,
Fukuda T, Mori T, Yano S, Kurokawa M,
Ueno H, Kanamori H, Hashimoto H,
Onizuka M, Takanashi M, Ichinohe T,
Atsuta Y, Ohashi K.

業績
番号100(3):29 WGP
6-306.
6-1

Am J
Hematol

2017

92(9):902 WGP-8.
6-2

Allogeneic hematopoietic stem cell
Itonaga H, Ota S, Ikeda T, Taji H, Amanotransplantation for the treatment of BCRI, Hasegawa Y, Ichinohe T, Fukuda T,
124 ABL1-negative atypical chronic myeloid
Leuk Res
Atsuta Y, Tanizawa A, Kondo T, Miyazaki
leukemia and chronic neutrophil leukemia:Y.
A retrospective nationwide study in Japan.

2018

75:50-7.

Comparison of Outcomes of Allogeneic
Transplantation for Primary Myelofibrosis
125
among Hematopoietic Stem Cell Source
Groups.

Murata M, Takenaka K, Uchida N, Ozawa
Y, Ohashi K, Kim SW, Ikegame K, Kanda Biol Blood
Y, Kobayashi H, Ishikawa J, Ago H,
Marrow
Hirokawa M, Fukuda T, Atsuta Y, Kondo Transplant
T.

2019

25(8):153 WGP
6-43.
6-4

Salvage allogeneic stem celltransplantation in patients with pediatric126
myelodysplastic syndrome andmyeloproliferative neoplasms.

Kato M, Yoshida N, Inagaki J, Maeba H,
Kudo K, Cho Y, Kurosawa H, Okimoto Y,
Tauchi H, Yabe H, Sawada A, Kato K,
Atsuta Y, Watanabe K.

Pediatr Blood
2014
Cancer61(10):18 WGP
60-6.
7-1

Clinical Outcomes after Allogeneic
Hematopoietic Stem Cell Transplantationin Children with Juvenile Myelomonocytic
127
Leukemia: A Report from the Japan
Society for Hematopoietic Cell
Transplantation.

Yoshida N, Sakaguchi H, Yabe M,
Hasegawa D, Hama A, Hasegawa D, Kato
M, Noguchi M, Terui K, Takahashi Y, Cho
Y, Sato M, Koh K, Kakuda H, Shimada H, Biol Blood
Hashii Y, Sato A, Kato K, Atsuta Y,
Marrow
Watanabe K; Pediatric Myelodysplastic
Transplant
Syndrome Working Group of the Japan
Society for Hematopoietic Cell
Transplantation.

2020

WGP
6-3

26(5):902 WGP
-10.
7-2

雑誌名

発行
年

刊・号・
頁

Aoki K , Ishikawa T, Ishiyama K, Aoki J,
Itonaga H, Fukuda T, Kakihana K, UchidaN, Ueda Y, Eto T, Mori T, Kondo T, Iwato
K, Morishima Y, Tanaka J, Atsuta Y,
Br J
Miyazaki Y; Adult Myelodysplastic
Haematol
Syndromes Working Group of the Japan
Society for Hematopoietic Cell
Transplantation (JSHCT).

2015

168(3):46 WGP
3-6.
8-1

Konuma T, Takahashi S, Uchida N,
Kuwatsuka Y, Yamasaki S, Aoki J, Onishi
Y, Aotsuka N, Ohashi K, Mori T, Masuko
Effect of Granulocyte Colony-Stimulating
M, Nakamae H, Miyamura K, Kato K,
Factor-Combined Conditioning in Cord
Biol Blood
Atsuta Y, Kato S, Asano S, Takami A,
129 Blood Transplantation for Myelodysplastic
Marrow
Miyazaki Y; Adult Myelodysplastic
Syndrome and Secondary Acute Myeloid
Transplant
Syndrome and Adult Acute Myeloid
Leukemia: A Retrospective Study in Japan.
Leukemia Working Group of the Japan
Society for Hematopoietic Cell
Transplantation.

201521(9):163 WGP
2-40.
8-2

Impacts of graft-versus-host disease on
outcomes after allogeneic hematopoietic
130 stem cell transplantation for chronic
myelomonocytic leukemia: A nationwide
retrospective study.

Itonaga H, Iwanaga M, Aoki K, Aoki J,
Ishiyama K, Ishikawa T, Sakura T, Fukuda
T, Najima Y, Yujiri T, Mori T, Kurokawa M,
Nawa Y, Uchida N, Morishita Y,
Leuk Res
Hashimoto H, Eto T, Hirokawa M,
Morishima Y, Nagamura-Inoue T, Atsuta
Y, Miyazaki Y.

2016

41:48-55.

Outcomes of Allogeneic Hematopoietic
Stem Cell Transplantation in Adult
131
Patients with Myelodysplastic Syndrome
Harboring Trisomy 8.

Konuma T, Miyazaki Y, Uchida N, Ohashi
K, Kondo T, Nakamae H, Takahashi S,
Mori T, Ozawa Y, Kato C, Iwato K, Fukuda Biol Blood
T, Ichinohe T, Atsuta Y, Ishiyama K; Adult Marrow
Myelodysplastic Syndrome Working Group Transplantof the Japan Society for Hematopoietic
Cell Transplantation.

2017

23(1):75- WGP
80.
8-4

2018

24(4):840 WGP-8.
8-5

Itonaga H, Ishiyama K, Aoki K, Aoki J,
Ishikawa T, Ohashi K, Fukuda T, Ozawa Y,
Bone Marrow
Ota S, Uchida N, Eto T, Iwato K, Ohno Y,
2019
Transplant
Takanashi M, Ichinohe T, Atsuta Y,
Miyazaki Y.

54(9):147 WGP
1-81.
8-6

論文タイトル

Allogeneic haematopoietic celltransplantation with reduced-intensity
128 conditioning for elderly patients withadvanced myelodysplastic syndromes: anationwide study.

Prognostic Impact of Donor Source on
Allogeneic Hematopoietic Stem Cell
Transplantation Outcomes in Adults with
132
Chronic Myelomonocytic Leukemia: A
Nationwide Retrospective Analysis inJapan.
Clinical impact of the loss of chromosome
7q on outcomes of patients with
133 myelodysplastic syndromes treated withallogeneic hematopoietic stem celltransplantation.

著者

Itonaga H, Aoki K, Aoki J, Ishikawa T,
Ishiyama K, Uchida N, Sakura T, Ohashi
K, Kurokawa M, Ozawa Y, Matsuoka KI,
Biol Blood
Nakamura Y, Kimura F, Iwato K, Nawa Y, Marrow
Hirokawa M, Kato K, Ichinohe T, Atsuta Y, TransplantMiyazaki Y.

Shimomura Y, Hara M, Tachibana T,
Outcomes of second allogeneic
Ohashi K, Sakura T, Fukuda T, Nakazawa
haematopoietic stem cell transplantation in
Br J
134
H, Iwato K, Kanda Y, Ikeda T, Eto T,
patients with relapse of myelodysplastic
HaematolKanda J, Ichinohe T, Atsuta Y, Ishikawa
syndrome.
T1, Ishiyama K.
Increased opportunity for prolonged
survival after allogeneic hematopoietic
135 stem cell transplantation in patients aged
60-69 years with myelodysplastic
syndrome.

Itonaga H, Ishiyama K, Aoki K, Aoki J,
Ishikawa T, Uchida N, Ohashi K, Ueda Y,
Fukuda T, Sakura T, Ohno Y, Iwato K,
Okumura H, Kondo T, Ichinohe T,
Takanashi M, Atsuta Y, Miyazaki Y.

業績
番号

WGP
8-3

2019

138(1):86 WGP
-90.
8-7

Ann Hematol 2019

98(6):136 WGP
7-81.
8-8

Ken Ishiyama, Jun Aoki, Hidehiro Itonaga,
Graft-versus-MDS effect after unrelated Naoyuki Uchida, Satoshi Takahashi, Yuju
cord blood transplantation: a retrospective Ohno, Yoshiko Matsuhashi, Toru Sakura,
Blood Cancer
136 analysis of 752 patients registered at the Makoto Onizuka, Shigesaburo Miyakoshi,
2019
JJapanese Data Center for Hematopoietic Minoko Takanashi, Takahiro Fukuda,
Cell Transplantation.
Yoshiko Atsuta, Shinji Nakao, Yasushi
Miyazaki.

9(3):31.

WGP
8-9

論文タイトル

Induction chemotherapy followed byallogeneic HCT versus upfront allogeneic
137 HCT for advanced myelodysplastic
syndrome: A propensity score matchedanalysis.

著者

雑誌名

発行
年

Konuma T, Shimomura Y, Ozawa Y, Ueda
Y, Uchida N, Onizuka M, Akiyama M, Mori
T, Nakamae H, Ohno Y, Shiratori S, Onishi
Hematological
Y, Kanda Y, Fukuda T, Atsuta Y, Ishiyama
2019
Oncology
K; Adult Myelodysplastic Syndrome
Working Group of the Japan Society for
Hematopoietic Cell Transplantation.

刊・号・
頁

業績
番号

37(1):85- WGP
95.
8-10

Shuhei Kurosawa , Yoshimitsu Shimomura
Outcome of Allogeneic Hematopoietic, Takayoshi Tachibana , Ken Ishiyama ,Stem Cell Transplantation in Patients with
Shuichi Ota , Takeshi Kobayashi , Naoyuki Biol Blood
Myelodysplastic/Myeloproliferative
138
Uchida , Kentaro Fukushima , Takashi
Marrow
Neoplasms-Unclassifiable: A Retrospective
Ashida , Ken-Ichi Matsuoka , Junya
Transplant
Nationwide Study of the Japan Society for
Kanda , Tatsuo Ichinohe , Yoshiko Atsuta
Hematopoietic Cell Transplantation.
, Makoto Murata , Jun Aoki.

2020

26(9):160 WGP
7-11.
8-11

Takaaki Konuma, Ken Ishiyama, Aiko
Igarashi, Naoyuki Uchida, Yukiyasu
Ozawa, Takahiro Fukuda, Yasunori Ueda,
Effects of Acute and Chronic GraftKen-Ichi Matsuoka, Takehiko Mori, Yuta
versus-myelodysplastic Syndrome on
Clin Cancer
139
Katayama, Makoto Onizuka, Tatsuo
Long-term Outcomes Following Allogeneic
Res
Ichinohe, Yoshiko Atsuta, Adult
Hematopoietic Cell Transplantation.
Myelodysplastic Syndrome Working Groupof the Japan Society for Hematopoietic
Cell Transplantation.

2020

26(24):64 WGP
83-93.
8-12

Michiko Kida, Kensuke Usuki, Naoyuki
Uchida, Takahiro Fukuda, Yuta Katayama,
Tadakazu Kondo, Tetsuya Eto, Ken-Ichi
Matsuoka, Yoshiko Matsuhashi, Shuichi
Biol Blood
Ota, Masashi Sawa, Toshihiro Miyamoto, Marrow
Tatsuo Ichinohe, Takafumi Kimura,Transplant
Yoshiko Atsuta, Akiyoshi Takami, Yasushi
Miyazaki, Shingo Yano, Ken Ishiyama,
Masamitsu Yanada, Jun Aoki.

2020

26(8):154 WGP
3-51.
8-13

Kobayashi R, Fujita N, Mitsui T, Iwasaki F,
Stem cell transplantation for paediatricSuzumiya J, Kuroda H, Nishimura R,
Br J
141 patients with non-anaplastic peripheral T- Sasahara Y, Takeshita Y, Kato K,
Haematolcell lymphoma in Japan.
Okumura H, Sakamaki H, Yabe H, Kawa K,
Kato K, Suzuki R.

2012

159(1):88 WGP
-93.
9-1

Fukano R, Mori T, Kobayashi R, Mitsui T,
Fujita N, Iwasaki F, Suzumiya J, Chin M,
Br J
Goto H, Takahashi Y, Hara J, Park YD,
HaematolInoue M, Koga Y, Inagaki J, Sakamaki H,
Adachi S, Kawa K, Kato K, Suzuki R.

2015

168(4):55 WGP
7-63.
9-2

Kobayashi R, Mitsui T, Fujita N, Osumi T,
Outcome differences between children and Aoki T, Aoki K, Suzuki R, Fukuda T,
adolescents and young adults with nonMiyamoto T, Kato K, Nakamae H, Goto H,
143
Int J Hematol 2017
Hodgkin lymphoma following stem cell
Eto T, Inoue M, Mori T, Terui K, Onizuka
transplantation.
M, Koh K, Koga Y, Ichinohe T, Sawada A,
Atsuta Y, Suzumiya J.

105(3):36 WGP
9-76.
9-3

Fujita N, Kobayashi R, Atsuta Y, Iwasaki
Hematopoietic stem cell transplantation in
F, Suzumiya J, Sasahara Y, Inoue M, Koh
144 children and adolescents with relapsed or
Int J Hematol 2019
K, Hori T, Goto H, Ichinohe T, Hashii Y,
refractory B-cell non-Hodgkin lymphoma.
Kato K, Suzuki R, Mitsui T.

109(4):48 WGP
3-90.
9-4

The effect of graft-versus-host disease on Mitsui T, Fujita N, Koga Y, Fukano R,
outcomes after allogeneic stem cell
Osumi T, Hama A, Koh K, Kakuda H,
145 transplantation for refractory
Inoue M, Fukuda T, Yabe H, Takita J,
lymphoblastic lymphoma in children andShimada A, Hashii Y, Sato A, Atsuta Y,
young adults.
Kanda Y, Suzumiya J, Kobayashi R.

67(4):e28 WGP
129.
9-5

140

Outcome and Risk Factors for TherapyRelated Myeloid Neoplasms Treated with
Allogeneic Stem Cell Transplantation in
Japan.

Haematopoietic stem cell transplantation
for relapsed or refractory anaplastic large
142
cell lymphoma: a study of children andadolescents in Japan.

Pediatr Blood
2020
Cancer論文タイトル

著者

雑誌名

発行
年

刊・号・
頁

業績
番号

The effectiveness of busulfan-based
conditioning regimens for stem cell
146 transplantation against lymphomas inchildren, adolescents, and young adults inJapan.

Hori D, Kobayashi R, Fujita N, SuzumiyaJ, Suzuki R, Kato K, Kawata T, Fukuda T,
Pediatr Blood
Inoue M, Goto H, Hama A, Iwato K,
2019
CancerOkumura H, Eto T, Hashii Y, Atsuta Y,
Mitsui T.

66(10):e2 WGP
7918.
9-6

Successful outcome with reducedintensity condition regimen followed by
147 allogeneic hematopoietic stem celltransplantation for relapsed or refractory
anaplastic large-cell lymphoma.

Fukano R, Mori T, Fujita N, Kobayashi R,
Mitsui T, Kato K, Suzuki R, Suzumiya J,
Fukuda T, Shindo M, Maseki , Shimoyama Int J Hematol 2019T, Okada K, Inoue M, Inagaki J, Hashii Y,
Sato A, Tabuchi K.

110(6):72 WGP
3-8.
9-7

High-dose chemotherapy with autologous
stem cell transplantation for elderly
148 patients with relapsed/refractory diffuse
large B cell lymphoma: a nationwide
retrospective study.

Chihara D, Izutsu K, Kondo E, Sakai R,
Mizuta S, Yokoyama K, Kaneko H, Kato K, Biol Blood
Hasegawa Y, Chou T, Sugahara H,
Marrow
Henzan H, Sakamaki H, Suzuki R,
Transplant
Suzumiya J.

201420(5):684 WGP
-9.
10-1

Kako S, Izutsu K, Kato K, Kim SW, Mori T,
Fukuda T, Kobayashi N, Taji H, Hashimoto
The role of hematopoietic stem cell
H, Kondo T, Sakamaki H, Morishima Y,
Am J
149 transplantation for relapsed and refractory Kato K, Suzuki R, Suzumiya J; Adult
Hematol
Hodgkin lymphoma.
Lymphoma Working Group of theJapanese Society for Hematopoietic Cell
Transplantation.

2015

90(2):132 WGP
-8.
10-2

Long-term survival following autologous
Aoki T, Suzuki R, Kuwatsuka Y, Kako S,
and allogeneic stem cell transplantation for Fujimoto K, Taguchi J, Kondo T, Ohata K,
150
Blood
blastic plasmacytoid dendritic cell
Ito T, Kamoda Y, Fukuda T, Ichinohe T,
neoplasm.
Takeuchi K, Izutsu K, Suzumiya J.

2015

125(23):3 WGP
559-62.
10-3

Yamasaki S, Suzuki R, Hatano K,
Fukushima K, Iida H, Morishima S, Suehiro
Y, Fukuda T, Uchida N, Uchiyama H, Ikeda
Bone Marrow
H, Yokota A, Tsukasaki K, Yamaguchi H,
2017
Transplant
Kuroda J, Nakamae H, Adachi Y,
Matsuoka KI, Nakamura Y, Atsuta Y,
Suzumiya J.

52(7):969 WGP
-76.
10-4

Yamasaki S, Chihara D, Yoshida I, Kohda
Impact of hematopoietic stem cell
K, Sawa M, Ago H, Togitani K, Ohno Y,
152 transplantation in patients with relapsed or
Ann Hematol 2019
Tanaka J, Fukuda T, Atsuta Y, Suzumiya
refractory marginal zone lymphoma.
J, Suzuki R.

98(6):152 WGP
1-3.
10-5

Yamasaki S, Chihara D, Kim SW, Kawata
Risk factors and timing of autologous stem T, Mizuta S, Ago H, Chou T, Yamane T,
153 cell transplantation for patients with
Uchiyama H, Oyake T, Miura K, Saito B,
peripheral T-cell lymphoma.
Taji H, Nakamae H, Miyamoto T, Fukuda
T, Kanda J, Atsuta Y, Suzuki R.

Int J Hematol 2019

109(2):17 WGP
5-86.
10-6

Yamasaki S, Chihara D, Kim SW, Izutsu K,
Impact of hematopoietic stem cellIwato K, Fukuda T, Uchida N, Amano I,
154 transplantation in patients with relapsed or Nakazawa H, Kuroda J, Hashimoto H,
Ann Hematol 2018refractory mantle cell lymphoma.
Ichinohe T, Kanda Y, Atsuta Y, SuzumiyaJ, Suzuki R.

97(8):144 WGP
5-52.
10-7

Kondo E, Ikeda T, Izutsu K, Chihara D,
High-Dose Chemotherapy with Autologous Shimizu-Koresawa R, Fujii N, Sakai T,
Stem Cell Transplantation in Primary
Kondo T, Kubo K, Kato Y, Akasaka T,
Biol Blood
155 Central Nervous System Lymphoma: Data Fukuda T, Ichinohe T, Atsuta Y, Suzumiya Marrow
From the Japan Society for Hematopoietic J, Suzuki R; Adult Lymphoma Working
Transplant
Cell Transplantation Registry.
Group of the Japan Society for
Hematopoietic Cell Transplantation.

2019

25(5):899 WGP
-905.
10-8

Yamasaki S, Nitta H, Kondo E, Uchida N,
Miyazaki T, Ishiyama K, Kiyota M,
Ann Hematol 2019
Matsuoka H, Ichinohe T, Fukuda T, Atsuta
Y, Suzumiya J, Suzuki R.

98(9):221 WGP
3-20.
10-9

Therapy-related acute myeloid leukemia
and myelodysplastic syndrome after151
hematopoietic cell transplantation for
lymphoma.

Effect of allogeneic hematopoietic celltransplantation for patients with Tprolymphocytic leukemia: a retrospective
156
study from the Adult Lymphoma Working
Group of the Japan Society forhematopoietic cell transplantation.

雑誌名

発行
年

刊・号・
頁

Clinical outcomes of hepatitis B or C virus
infections in patients with malignant
Kato H, Kato K, Kim SW, Fukuda T, Morilymphoma receiving autologous stem cellT, Sawa M, Ohno Y, Yoshioka S, Iwato Y, Br J
157 transplantation: on behalf of the Adult
Taji H, Onizuka M, Kurahashi S, Ichinohe Haematol
Lymphoma Working Group of the JapanT, Suzumiya J, Suzuki R.
Society for Haematopoietic Cell
Transplantation (JSHCT).

2019

186(6):e1 WGP
70-5.
10-10

Outcome of patients receiving
consolidative autologous peripheral blood Kato K, Mori T, Kim SW, Sawa M, Sakai T,
stem cell transplantation in the frontline
Hashimoto H, Taguchi J, Oyake T,
Bone Marrow
158 treatment of intravascular large B-cell
Kurahashi S, Imada K, Ohno H, Tanaka J,
2019
Transplant
lymphoma: Adult Lymphoma Working Group Ichinohe T, Atsuta Y, Suzuki R, Suzumiyaof the Japan Society for Hematopoietic
J.
Cell Transplantation.

54(9):151 WGP
5-7.
10-11

Allogeneic haematopoietic stem celltransplantation for primary mediastinal
Kondo E, Shimizu-Koresawa R, Chihara
large B-cell lymphoma patients relapsing D, Mizuta S, Izutsu K, Ikegame K, Uchida
Br J
159 after high dose chemotherapy with
N, Fukuda T, Ichinohe T, Atsuta Y, Suzuki
Haematolautologous stem cell transplantation: data R; Adult Lymphoma Working Group of thefrom the Japan Society for Haematopoietic JSHCT.
Cell Transplantation registry.

2019

186(6):e2 WGP
19-23.
10-12

Ayumi Fujimoto, Fumihiro Ishida, Koji
Izutsu, Satoshi Yamasaki, Dai Chihara,
Allogeneic stem cell transplantation for
Junji Suzumiya, Tetsuo Mitsui, Noriko
160
patients with aggressive NK-cell leukemia. Doki, Hitoshi Sakai, Hikaru Kobayashi,
Junya Kanda, Takahiro Fukuda, Yoshiko
Atsuta, Ritsuro Suzuki.

Bone Marrow
2021
Transplant56(2):347 WGP
-56.
10-13

Takehiko Mori, Souichi Shiratori, Junji
Suzumiya, Mineo Kurokawa, Motohiro
Outcome of allogeneic hematopoietic stem
Shindo, Uchida Naoyuki, Takenaka
161 cell transplantation for mycosis fungoides
Katsuto, Toshihiro Miyamoto, Satoshi
and Sézary syndrome.
Morishige, Makoto Hirokawa, Takahiro
Fukuda, Yoshiko Atsuta, Ritsuro Suzuki.

Hematological2020
Oncology

38(3):266 WGP
-71.
10-14

Tsutomu Takahashi , Ritsuro Suzuki , Go
Yamamoto , Hideyuki Nakazawa ,Hematopoietic stem cell transplantation for Mitsutoshi Kurosawa , Tsutomu
Hematological
162 diffuse large B-cell lymphoma having
Kobayashi , Masaya Okada , Takashi
2021
Oncology
8q24/MYC rearrangement in Japan.
Akasaka , Sung-Won Kim , Takahiro
Fukuda , Tatsuo Ichinohe , Yoshiko
Atsuta , Junji Suzumiya.

39(1):66- WGP
74.
10-15

Outcome of stem cell transplantation for
Waldenström's macroglobulinemia: analysis
163 of the Japan Society for Hematopoietic
Cell Transplantation (JSHCT) Lymphoma
Working Group.

Masatoshi Sakurai , Takehiko Mori , Hitoji
Uchiyama , Hiroatsu Ago , Koji Iwato ,Tetsuya Eto , Hiromi Iwasaki , Takahito
Kawata , Hiroyuki Takamatsu , Satoshi
Ann Hematol 2020
Yamasaki , Minoko Takanashi , Tatsuo
Ichinohe , Yoshiko Atsuta , Ritsuro
Suzuki.

99(7):163 WGP
5-42.
10-16

Long-term outcome of childhood aplastic
anemia patients who underwent allogeneic
hematopoietic SCT from an HLA-matchedsibling donor in Japan.

Kikuchi A, Yabe H, Kato K, Koh K, Inagaki
J, Sasahara Y, Suzuki R, Yoshida N, Kudo Bone Marrow
2013
K, Kobayashi R, Tabuchi K, Kawa K,
Transplant
Kojima S.

48(5):657 WGP
-60.
11-1

Yoshida N, Kobayashi R, Yabe H, Kosaka
First-line treatment for severe aplastic
Y, Yagasaki H, Watanabe K, Kudo K,
anemia in children: bone marrow
Haematologic
165
Morimoto A, Ohga S, Muramatsu H,
2014
transplantation from a matched familyaTakahashi Y, Kato K, Suzuki R, Ohara A,
donor versus immunosuppressive therapy.
Kojima S.

99(12):17 WGP
84-91.
11-2

論文タイトル

164

Bloodstream infection after stem cell
166 transplantation in children with idiopathic
aplastic anemia.

著者

Kobayashi R, Yabe H, Kikuchi A, Kudo K,
Yoshida N, Watanabe K, Muramatsu H,
Biol Blood
Takahashi Y, Inoue M, Koh K, Inagaki J,
Marrow
Okamoto Y, Sakamaki H, Kawa K, Kato K, Transplant
Suzuki R, Kojima S.

2014

業績
番号

20(8):114 WGP
5-9.
11-3

論文タイトル

著者

雑誌名

発行
年

Kudo K, Muramatsu H, Yoshida N,
Second allogeneic hematopoietic stem cell Kobayashi R, Yabe H, Tabuchi K, Kato K,
Bone Marrow
167 transplantation in children with severe
Koh K, Takahashi Y, Hashii Y, Kawano Y,
2015
Transplant
aplastic anemia.
Inoue M, Cho Y, Sakamaki H, Kawa K,
Kato K, Suzuki R, Kojima S.
Unrelated cord blood transplantation in
168 aplastic anemia: is antithymocyte globulin
indispensable for conditioning?

Kudo K, Muramatsu H, Narita A, Yoshida
N, Kobayashi R, Yabe H, Endo M, Inoue M,
Bone Marrow
Hara J, Kounami S, Inagaki J, Hashii Y,
2017Transplant
Kato K, Tabuchi K, Kojima S.

刊・号・
頁

業績
番号

50(10):13 WGP
12-5.
11-4

52(12):16 WGP
59-61.
11-5

Nao Yoshida, Yoshiyuki Takahashi,
Hiromasa Yabe, Ryoji Kobayashi,
Kenichiro Watanabe, Kazuko Kudo, Miharu
Conditioning Regimen for Allogeneic Bone Yabe, Takako Miyamura, Katsuyoshi Koh,
Marrow Transplantation in Children With
Hiroshi Kawaguchi, Hiroaki Goto, Naoto
Bone Marrow
169 Acquired Bone Marrow Failure:
Fujita, Keiko Okada, Yasuhiro Okamoto,2020
Transplant
Fludarabine/Melphalan vs.
Koji Kato, Masami Inoue, Ritsuro Suzuki,
Fludarabine/Cyclophosphamide.
Yoshiko Atsuta, Seiji Kojima, Pediatric
Aplastic Anemia Working Group of theJapan Society for Hematopoietic Cell
Transplantation.

55(7):127 WGP
2-81.
11-6

Impact of cyclophosphamide dose ofMori T, Koh H, Onishi Y, Kako S, Onizuka
conditioning on the outcome of allogeneic
M, Kanamori H, Ozawa Y, Kato C, Iida H,
170 hematopoietic stem cell transplantation for
Int J Hematol 2016
Suzuki R, Ichinohe T, Kanda Y, Maeda T,
aplastic anemia from human leukocyte
Nakao S, Yamazaki H.
antigen-identical sibling.

103(4):46 WGP
1-8.
12-1

Onishi Y, Mori T, Kako S, Koh H, Uchida
N, Kondo T, Kobayashi T, Yabe H,
Outcome of Second Transplantation Using Miyamoto T, Kato K, Suzuki R, Nakao S,
Umbilical Cord Blood for Graft Failure after Yamazaki H; Adult Aplastic Anemia
171
Allogeneic Hematopoietic Stem Cell
Working Group of the Japan Society forTransplantation for Aplastic Anemia.
Hematopoietic Cell Transplantation.

Biol Blood
Marrow
Transplant2017

23(12):21 WGP
37-42.
12-2

Mori T, Onishi Y, Ozawa Y, Kato C, Kai T,
Outcome of allogeneic hematopoietic stem
Kanda Y, Kurokawa M, Tanaka M, Ashida
172 cell transplantation in adult patients withInt J Hematol 2019
T, Sawayama Y, Fukuda T, Ichinohe T,
hepatitis-associated aplastic anemia.
Atsuta Y, Yamazaki H.

109(6):71 WGP
1-7.
12-3

Mixed Chimerism and Secondary Graft
173 Failure in Allogeneic Hematopoietic Stem
Cell Transplantation for Aplastic Anemia.

Kako S, Yamazaki H, Ohashi K, Ozawa Y,
Ota S, Kanda Y, Maeda T, Kato J,
Ishiyama K, Matsuoka KI, Miyamoto T, Iida Biol Blood
H, Ikegame K, Fukuda T, Ichinohe T,
Marrow
Atsuta Y, Mori T; Adult Aplastic Anemia Transplant
Working Group of the Japanese Societyfor Hematopoietic Cell Transplantation.

2020

26(3):445 WGP
-50.
12-4

Cyclosporine/methotrexate versus
tacrolimus/methotrexate with or without
174 anti-thymocyte globulin as GVHD
prophylaxis in adult patients with aplastic
anemia.

Yasushi Onishi , Takehiko Mori , Hirohito
Yamazaki , Katsuto Takenaka , Hiroki
Yamaguchi , Naoki Shingai , Yukiyasu
Ozawa , Hiroatsu Iida , Shuichi Ota ,Naoyuki Uchida , Toshihiro Miyamoto ,Yuta Katayama , Jun Kato , Satoshi
Ann Hematol 2021
Yoshioka , Makoto Onizuka , Tatsuo
Ichinohe , Yoshiko Atsuta , Adult Aplastic
Anemia Working Group of the Japan
Society for Hematopoietic Cell
Transplantation.

100(1):21 WGP
7-28.
12-5

論文タイトル

著者

Yukinori Nakamura , Katsuto Takenaka ,Hirohito Yamazaki , Yasushi Onishi ,Outcome of allogeneic hematopoietic stem Yukiyasu Ozawa , Kazuhiro Ikegame ,175 cell transplantation in adult patients with Ken-Ichi Matsuoka , Tomomi Toubai ,paroxysmal nocturnal hemoglobinuria.
Yasunori Ueda , Yoshinobu Kanda ,Tatsuo Ichinohe , Yoshiko Atsuta ,Takehiko Mori.

雑誌名

発行
年

Int J Hematol 2021

刊・号・
頁

業績
番号

113(1):12 WGP
2-7.
12-6

Allogeneic hematopoietic stem celltransplantation for adult T-cell leukemia176 lymphoma with special emphasis on
preconditioning regimen: a nationwide
retrospective study.

Ishida T, Hishizawa M, Kato K, Tanosaki
R, Fukuda T, Taniguchi S, Eto T,
Takatsuka Y, Miyazaki Y, Moriuchi Y,
Blood
Hidaka M, Akashi K, Uike N, Sakamaki H,
Morishima Y, Kato K, Suzuki R, Nishiyama
T, Utsunomiya A.

2012

120(8):17 WGP
34-41.
13-1

Impact of graft-versus-host disease on
allogeneic hematopoietic cell
177 transplantation for adult T cell leukemialymphoma focusing on preconditioning
regimens: nationwide retrospective study.

Ishida T, Hishizawa M, Kato K, Tanosaki
R, Fukuda T, Takatsuka Y, Eto T,
Miyazaki Y, Hidaka M, Uike N, Miyamoto
T, Tsudo M, Sakamaki H, Morishima Y,
Suzuki R, Utsunomiya A.

Biol Blood
Marrow
Transplant2013

19(12):17 WGP
31-9.
13-2

Treatment of patients with adult T cellleukemia/lymphoma with cord blood
178
transplantation: a Japanese nationwide
retrospective survey.

Kato K, Choi I, Wake A, Uike N, Taniguchi
S, Moriuchi Y, Miyazaki Y, Nakamae H,
Biol Blood
Oku E, Murata M, Eto T, Akashi K,
Marrow
Sakamaki H, Kato K, Suzuki R, Yamanaka Transplant
T, Utsunomiya A.

2014

20(12):19 WGP
68-74.
13-3

Early application of related SCT might
179 improve clinical outcome in adult T-cellleukemia/lymphoma.

Fuji S, Fujiwara H, Nakano N, Wake A,
Inoue Y, Fukuda T, Hidaka M, Moriuchi Y,
Miyamoto T, Uike N, Taguchi J, Eto T,
Bone Marrow
Tomoyose T, Kondo T, Yamanoha A,
2016
Transplant
Ichinohe T, Atsuta Y, Utsunomiya A; ATL
Working Group of the Japan Society for
Hematopoietic Cell Transplantation.

51(2):205 WGP
-11.
13-4

Fujiwara H, Fuji S, Wake A, Kato K,
Takatsuka Y, Fukuda T, Taguchi J, Uchida
Dismal outcome of allogeneic
N, Miyamoto T, Hidaka M, Miyazaki Y,
hematopoietic stem cell transplantation forBone Marrow
180
Tomoyose T, Onizuka M, Takanashi M,
2017relapsed adult T-cell leukemia/lymphoma,
Transplant
Ichinohe T, Atsuta Y, Utsunomiya A; ATLa Japanese nation-wide study.
Working Group of the Japan Society for
Hematopoietic Cell Transplantation.

52(3):484 WGP
-8.
13-5

Risk Assessment in Adult T Cell
Leukemia/Lymphoma Treated with
181 Allogeneic Hematopoietic Stem Cell
Transplantation.

The outcome and characteristics ofpatients with relapsed adult T cell182
leukemia/lymphoma after allogeneic
hematopoietic stem cell transplantation.

Yoshimitsu M, Tanosaki R, Kato K, Ishida
T, Choi I, Takatsuka Y, Fukuda T, Eto T,
Hidaka M, Uchida N, Miyamoto T,
Nakashima Y, Moriuchi Y, Nagafuji K,
Biol Blood
Miyazaki Y, Ichinohe T, Takanashi M,
Marrow
Atsuta Y, Utsunomiya A; ATL Working
TransplantGroup of the Japan Society for
Hematopoietic Cell Transplantation.

2018

Kato K, Uike N, Wake A, Yoshimitsu M,
Tobai T, Sawayama Y, Takatsuka Y,
Fukuda T, Uchida N, Eto T, Nakashima Y,
Kondo T, Taguchi J, Miyamoto T,
HematologicalNakamae H, Ichinohe T, Kato K, Suzuki R,
2019
Oncology
Utsunomiya A; ATL Working Group of theJapan Society for Hematopoietic Cell
Transplantation.

24(4):832 WGP
-9.
13-6

37(1):54- WGP
61.
13-7

論文タイトル

著者

雑誌名

発行
年

刊・号・
頁

業績
番号

Yoshimitsu M, Utsunomiya A, Fuji S,
A retrospective analysis of haplo-identical Fujiwara H, Fukuda T, Ogawa H,
HLA-mismatch hematopoietic
Takatsuka Y, Ishitsuka K, Yokota A,
transplantation without posttransplantation Okumura H, Ishii K, Nishikawa A, Eto T,
Bone Marrow
183
2019
cyclophosphamide for GVHD prophylaxis in Yonezawa A, Miyashita K, Tsukada J,
Transplantpatients with adult T-cell leukemiaTanaka J, Atsuta Y, Kato K; ATL Working
lymphoma.
Group of the Japan Society for
Hematopoietic Cell Transplantation.

54(8):126 WGP
6-74.
13-8

Sawayama Y, Itonaga H, Fukushima T,
Cytomegalovirus reactivation is associated Nakano N, Fujiwara H, Utsunomiya A,
with increased mortality more than 100
Fukuda T, Miyamoto T, Eto T, Miyashita
Am J
184 days after allogeneic hematopoietic stem K, Nakamae H, Ogata M, Yamanoha A,
Hematolcell transplantation for adult T-cell
Miyazaki Y, Kanda J, Atsuta Y, Kato K;
leukemia/lymphoma.
ATL Working Group of the Japan Societyfor Hematopoietic Cell Transplantation.

2019

94(5):E14 WGP
3-6.
13-9

Yoshimitsu M, Fuji S, Utsunomiya A,
Nakano N, Ito A, Ito Y, Miyamoto T,
Suehiro Y, Kawakita T, Moriuchi Y,
Biol Blood
Nakamae H, Kanda Y, Ichinohe T, Fukuda Marrow
T, Atsuta Y, Kato K; ATL Working Group Transplantof the Japan Society for Hematopoietic
Cell Transplantation.

2020

26(4):718 WGP
-22.
13-10

Shigeo Fuji, Saiko Kurosawa, Yoshihiro
Inamoto, Nobuaki Nakano, Yasuhiko
Miyazaki, Kaname Miyashita, Michihiro
Does an increased probability of graft‐vs‐ Hidaka, Tetsuya Eto, Naoyuki Uchida,
host disease improve the survival of
Asahi Ito, Yasushi Sawayama, Toshihiro
Adv Cell
186 patients with adult T‐cell leukemia‐
Miyamoto, Junji Suzumiya, Atae
Gene Therlymphoma? A simulation analysis using a
Utsunomiya, Junya Kanda, Yoshiko
Markov model.
Atsuta, Takahiro Fukuda, Koji Kato, on
behalf of Adult T‐cell Leukemia‐Working
Group of Japan Society of Hematopoietic
Cell Transplantation.

2019

2:e56.

Outcomes of Allogeneic Hematopoietic
185 Stem Cell Transplantation for ATL with
HTLV-1 Antibody-Positive Donors.

WGP
13-11

Hiroyuki Muranushi , Takero Shindo ,Masakatsu Hishizawa , Masahito
Tokunaga , Atsushi Wake , Nobuaki
Nakano , Tetsuya Eto , Michihiro Hidaka ,GVHD-free, relapse-free survival provides Ilseung Choi , Toshihiro Miyamoto ,Bone Marrow
187 novel clues for optimizing allogeneic-HSCT Naoyuki Uchida , Yukiyoshi Moriuchi ,2021
Transplant
for adult T-cell leukemia/lymphoma.
Yasuhiko Miyazaki , Takahiro Fukuda ,Tatsuo Ichinohe , Yoshiko Atsuta , ATL
Working Group of the Japanese Societyfor Hematopoietic Cell Transplantation;
Koji Kato.

56(1):155 WGP
-66.
13-12

Nobuaki Nakano , Atae Utsunomiya ,Keitaro Matsuo , Noriaki Yoshida , Masao
Seto , Kouichi Ohshima , Hiroshi Fujiwara, Shigeo Fuji , Yoshifusa Takatsuka ,Chromosomal defects and survival in
Ayumu Ito , Toshihiro Miyamoto , Youko Blood
188 patients with adult T-cell
Suehiro , Hirohisa Nakamae , Yasushi
Advancesleukemia/lymphoma after allogeneic HSCT.
Sawayama , Mitsuhiro Yuasa , Yasuhiko
Miyazaki , Shuichi Ota , Kazunori Imada ,Takahiro Fukuda , Tatsuo Ichinohe ,Yoshiko Atsuta , Koji Kato.

2021

5(2):475- WGP
86.
13-13

Changing trends in prognostic factors for
Takamatsu H, Honda S, Miyamoto T,
patients with multiple myeloma after
Yokoyama K, Hagiwara S, Ito T, Tomita N,
189 autologous stem cell transplantation during
Cancer Sci
Iida S, Iwasaki T, Sakamaki H, Suzuki R,
the immunomodulator drug/proteasome
Sunami K.
inhibitor era.

2015

106(2):17 WGP
9-85.
14-1

雑誌名

発行
年

刊・号・
頁

Cord Blood Transplantation for Multiple
Myeloma:A Study from the Multiple
190 Myeloma Working Group of the Japan
Society for Hematopoietic Cell
Transplantation.

Kawamura K, Takamatsu H, Ikeda T,
Komatsu T, Aotsuka N, Amano I,
Biol Blood
Yamamoto G, Watanabe K, Ohno Y,
Marrow
Matsue K, Kouzai Y, Tsukada N, Ishiyama
Transplant
K, Anzai N, Kato K, Suzuki R, Sunami K,
Kanda Y.

2015

21(7):129 WGP
1-8.
14-2

Tandem autologous versus
autologous/allogeneic transplantation for
191
multiple myeloma: propensity scoreanalysis.

Kawamura K, Ikeda T, Hagiwara S, Mori T,
Shinagawa A, Nishiwaki K, Ohashi K,
Leuk
Kubonishi S, Fukuda T, Ito T, Tomita N,
LymphomaIchinohe T, Kato K, Morishima Y, Atsuta
Y, Sunami K, Kanda Y.

2016

57(9):207 WGP
7-83.
14-3

Significance of Salvage Autologous Stem
Cell Transplantation for Relapsed Multiple
192
Myeloma: A Nationwide Retrospective
Study in Japan.

Muta T, Miyamoto T, Kamimura T, Kanda
Y, Nohgawa M, Ueda Y, Iwato K, Sasaki O, Acta
Mori T, Uchida N, Iida S, Fukuda T,
Haematol
Atsuta Y, Sunami K.

2018

139(1):35 WGP
-44.
14-4

Takamatsu H, Yamashita T, Kurahashi S,
Clinical Implications of t(11;14) in Patients Saitoh T, Kondo T, Maeda T, Nakazawa H, Biol Blood
193 with Multiple Myeloma Undergoing
Murata M, Narita T, Kuroda J, Hashimoto Marrow
Autologous Stem Cell Transplantation.
H, Kawamura K, Miyamoto T, Honda S,
Transplant
Ichinohe T, Atsuta Y, Sunami K.

201925(3):474 WGP
-9.
14-5

Bone Marrow
2019
Transplant54(10):15 WGP
95-604.
14-6Comparison between autologous andallogeneic stem cell transplantation as
195 salvage therapy for multiple myeloma
relapsing/progressing after autologous
stem cell transplantation.

Ikeda T, Mori K, Kawamura K, Mori T,
Hagiwara S, Ueda Y, Kahata K, Uchida N,
Tsukada N, Murakami S, Yamamoto M,
Hematological
2019
Takahashi T, Ichinohe T, Onizuka M,
Oncology
Atsuta Y, Kanda Y, Okamoto S, Sunami K,
Takamatsu H.

37(5):586 WGP
-94.
14-7

Efficacy of high-dose chemotherapy with
196 stem cell transplantation
for hepatoblastoma in Japan.

山本将平，渡邊健一郎，井上雅美，橋井 日本小児血佳子，菊田 敦，金子 隆，加藤剛二，原 液・がん学会 2017
純一，田渕 健，高橋義行.
雑誌54(2):126 WGP
-32.
15-1

Autologous Stem Cell Transplantation forChildren With Renal Tumors, and Adults
197 With Wilms Tumor: Retrospective Analysisof the Japanese Transplant Registry
Unified Management Program.

Ryoji Kobayashi , Masami Inoue ,Yoshiyuki Takahashi , Atsushi Kikuta ,J Pediatr
Atsushi Ogawa , Yuhki Koga , Katsuyoshi
Hematol
Koh , Yoshiko Hashii , Junichi Hara , Koji
Oncol
Kato , Ken Tabuchi , Kimikazu
Matsumoto.

2020

42(4):251 WGP
-5.
15-2

Pediatr Blood
2016
Cancer63(12):22 WGP
21-9.
16-1

論文タイトル

著者

Mizuno S, Kawamura K, Hanamura I,
Efficacy and safety of autologous stem cell
Sunami K, Mori T, Nakamura F, Iida S,
transplantation in patients aged ≥ 65 years
194
Nakazawa H, Makita M, Kako S, Sawa M,
with multiple myeloma in the era of novel
Ueda Y, Takahashi H, Kanda Y, Ichinohe
agents.
T, Atsuta Y, Takamatsu H, Takami A.

Umeda K, Adachi S, Tanaka S, Miki M,
Comparison of second transplantation and Okada K, Hashii Y, Inoue M, Cho Y, Kohdonor lymphocyte infusion for donor mixed K, Goto H, Kajiwara R, Hyakuna N, Kato
198
chimerism after allogeneic stem cell
K, Morio T, Yabe H; Inherited Diseasetransplantation for nonmalignant diseases. Working Group of the Japan Society for
Hematopoietic Cell Transplantation.
Allogeneic Hematopoietic Stem Cell
Transplantation for Leukocyte Adhesion
199
Deficiency.

Horikoshi Y, Umeda K, Imai K, Yabe H,
J Pediatr
Sasahara Y, Watanabe K, Ozawa Y, Hashii
HematolY, Kurosawa H, Nonoyama S, Morio T.
Oncol

Umeda K, Yabe H, Kato K, Imai K,
Impact of low-dose irradiation and in vivo Kobayashi M, Takahashi Y, Yoshida N,
T-cell depletion on hematopoietic stem
Sato M, Sasahara Y, Kato K, Adachi S,
200 cell transplantation for non-malignant
Koga Y, Okada K, Inoue M, Hashii Y,
diseases using fludarabine-based reduced- Atsuta Y, Morio T; Inherited Diseaseintensity conditioning.
Working Group of the Japan Society for
Hematopoietic Cell Transplantation.

業績
番号

2018

40(2):137 WGP
-40.
16-2

Bone Marrow
2019
Transplant54(8):122 WGP
7-36.
16-3

論文タイトル

著者

雑誌名

発行
年

刊・号・
頁

業績
番号

Iguchi A, Cho Y, Yabe H, Kato S, Kato K,
Long-term outcome and chimerism inHara J, Koh K, Takita J, Ishihara T, Inouepatients with Wiskott-Aldrich syndrome
M, Imai K, Nakayama H, Hashii Y,
201 treated by hematopoietic cell
Morimoto A, Atsuta Y, Morio T;
Int J Hematol 2019transplantation: a retrospective nationwide Hereditary disorder Working Group of thesurvey.
Japan Society for Hematopoietic Cell
Transplantation.

110(3):36 WGP
4-9.
16-4

Katsutsugu Umeda, Kohsuke Imai,
Masakatsu Yanagimachi, Hiromasa Yabe,
Masao Kobayashi, Yoshiyuki Takahashi,
Michiko Kajiwara, Nao Yoshida, Yuko Cho,
Masami Inoue, Yoshiko Hashii, Yoshiko
Int J Hematol 2020
Atsuta, Tomohiro Morio, Inherited
Disease Working Group of the Japan
Society for Hematopoietic Cell
Transplantation.

111(6):86 WGP
9-76.
16-5

Miharu Yabe , Tomohiro Morio , Ken
Tabuchi , Daisuke Tomizawa , Daiichiro
Hasegawa , Hiroyuki Ishida , Nao YoshidaLong-term outcome in patients with
, Takashi Koike , Yoshiyuki Takahashi ,Fanconi anemia who received
Katsuyoshi Koh , Yasuhiro Okamoto ,203
Int J Hematol 2021
hematopoietic stem cell transplantation: a Hideki Sano , Keisuke Kato , Yoshinobu
retrospective nationwide analysis.
Kanda , Hiroaki Goto , Junko Takita ,Takako Miyamura , Maiko Noguchi , Koji
Kato , Yoshiko Hashii , Yoshiko Astuta ,Hiromasa Yabe.

113(1):13 WGP
4-44.
16-6

Impact of Graft-Versus-Host Disease on
the Clinical Outcome of Allogeneic
202
Hematopoietic Stem Cell Transplantation
for Non-Malignant Diseases.

Masakatsu Yanagimachi, Koji Kato, Akihiro
Iguchi, Koji Sasaki, Chikako Kiyotani,
Katsuyoshi Koh, Takashi Koike, Hideki
Sano, Tomonari Shigemura, Hideki
Front
Muramatsu, Keiko Okada, Masami Inoue, Immunol
Ken Tabuchi, Toyoki Nishimura, Tomoyuki
Mizukami, Hiroyuki Nunoi, Kohsuke Imai,
Masao Kobayashi, Tomohiro Morio.

2020

11:1617.

Impact of a single human leucocyte antigen(HLA) allele mismatch on the outcome of
Kanda Y, Kanda J, Atsuta Y, Maeda Y,
unrelated bone marrow transplantation
Ichinohe T, Ohashi K, Fukuda T, Miyamura Br J
205 over two time periods. A retrospective
K, Iida H, Mori T, Iwato K, Eto T, Kawa K, Haematol
analysis of 3003 patients from the HLA
Morita S, Morishima Y.
Working Group of the Japan Society for
Blood and Marrow Transplantation.

2013

161(4):56 WGP
6-77.
17-1

204

Hematopoietic Cell Transplantation for
Chronic Granulomatous Disease in Japan.

Effects of KIR ligand incompatibility on
clinical outcomes of umbilical cord blood
206
transplantation without ATG for acuteleukemia in complete remission.

Tanaka J, Morishima Y, Takahashi Y,
Yabe T, Oba K, Takahashi S, Taniguchi S,
Blood Cancer
Ogawa H, Onishi Y, Miyamura K, Kanamori
2013
J
H, Aotsuka N, Kato K, Kato S, Atsuta Y,
Kanda Y.

Atsuta Y, Kanda J, Takanashi M,
Morishima Y, Taniguchi S, Takahashi S,
Different effects of HLA disparity on
Ogawa H, Ohashi K, Ohno Y, Onishi Y,
transplant outcomes after single-unit cord
207
Aotsuka N, Nagamura-Inoue T, Kato K,
blood transplantation between pediatricKanda Y; HLA Working Group of theand adult patients with leukemia.
Japan Society for Hematopoietic Cell
Transplantation.

Impact of the direction of HLA mismatch
208 on transplantation outcomes in single
unrelated cord blood transplantation.

Haematologic
2013aKanda J, Atsuta Y, Wake A, Ichinohe T,
Takanashi M, Morishima Y, Taniguchi S,
Takahashi S, Ogawa H, Ohashi K, Ohno Y, Biol Blood
Aotsuka N, Onishi Y, Kato K, Nagamura- Marrow
Inoue T, Kanda Y; HLA Working Group of Transplant
the Japan Society for Hematopoietic Cell
Transplantation.

2013

3:e164.

WGP
16-7

WGP
17-2

98(5):814 WGP
-22.
17-3

19(2):247 WGP
-54.
17-4

雑誌名

発行
年

刊・号・
頁

Kanda Y, Kanda J, Atsuta Y, Fuji S,
Maeda Y, Ichinohe T, Takanashi M,
Changes in the clinical impact of high-risk
Ohashi K, Fukuda T, Miyamura K, Mori T, Biol Blood
human leukocyte antigen allele mismatch
209
Sao H, Kobayashi N, Iwato K, Sawada A, Marrowcombinations on the outcome of unrelatedMori S; HLA working group of the Japan Transplantbone marrow transplantation.
Society for Hematopoietic Cell
Transplantation.

2014

20(4):526 WGP
-35.
17-5

論文タイトル

著者

Kanda J, Fuji S, Kato S, Takami A,
Tanaka J, Miyamura K, Ohashi K, Fukuda
T, Ozawa Y, Kanamori H, Eto T,
Decision analysis for donor selection in
Kobayashi N, Iwato K, Morishima Y,
stem cell transplantation-HLA-8/8 alleleBlood Cancer
210
Sakamaki H, Atsuta Y, Kanda Y; HLA
2014
matched unrelated donor vs HLA-1 AG
J
Working Group; Donor/Source Working
mismatched related donor.
Group; Adult AML Working Group; Adult
ALL Working Group of the Japan Societyfor Hematopoietic Cell Transplantation.

4:e263.

業績
番号

WGP
17-6

Impact of HLA allele mismatch on the
211 clinical outcome in serologically matched
related hematopoietic SCT.

Fuji S, Kanda J, Kato S, Ikegame K,
Morishima S, Miyamoto T, Hidaka M, Kubo
K, Miyamura K, Ohashi K, Kobayashi H,
Bone Marrow
Maesako Y, Adachi S, Ichinohe T, Atsuta
2014
Transplant
Y, Kanda Y; HLA Working Group of Japan
Society for Hematopoietic Cell
Transplantation.

49(9):118 WGP
7-92.
17-7

Impact of HLA mismatch direction on theoutcome of unrelated bone marrow
212 transplantation: a retrospective analysis
from the Japan Society for Hematopoietic
Cell Transplantation.

Kanda J, Ichinohe T, Fuji S, Maeda Y,
Ohashi K, Fukuda T, Miyamura K, Iwato K,
Biol Blood
Eto T, Nakamae H, Kobayashi N, Mori T,
MarrowMori S, Morishima Y, Atsuta Y, Kanda Y;
Transplant
HLA Working Group of the Japan Societyfor Hematopoietic Cell Transplantation.

201521(2):305 WGP
-11.
17-8

Fuji S, Kanda J, Kato S, Ikegame K,
A single high-resolution HLA mismatch has Morishima S, Miyamoto T, Hidaka M, Kubo
a similar adverse impact on the outcome K, Miyamura K, Tsudo M, Kobayashi H,
Am J
213 of related hematopoietic stem cell
Maesako Y, Eto T, Adachi S, Ichinohe T,
Hematoltransplantation as a single low-resolution Atsuta Y, Kanda Y; HLA Working Group of
HLA mismatch.
the Japan Society for Hematopoietic Cell
Transplantation.

2015

90(7):618 WGP
-23.
17-9

Yanada M, Kanda J, Ohtake S, Fukuda T,
Sakamaki H, Miyamura K, Miyawaki S,
Uchida N, Maeda T, Nagamura-Inoue T, Eur J
Asou N, Morishima Y, Atsuta Y, Miyazaki HaematolY, Kimura F, Kobayashi Y, Takami A, Naoe
T, Kanda Y.

2016

97(3):278 WGP
-87.
17-10

Arima N, Nakamura F, Yabe T, Tanaka J,
Influence of Differently Licensed KIR2DL1Fuji S, Ohashi K, Fukuda T, Miyamura K, Biol Blood
Positive Natural Killer Cells in Transplant
215
Iwato K, Eto T, Mori T, Kobayashi N,
Marrow
Recipients with Acute Leukemia: A
Hoshino T, Kato C, Kanamori H, Nakamae Transplant
Japanese National Registry Study.
H, Atsuta Y, Morishima Y, Kanda Y.

201622(3):423 WGP
-31.
17-11

Kanda J, Ikegame K, Fuji S, Kurokawa M,
Kanamori H, Fukuda T, Ohashi K, Ishikawa
Biol BloodJ, Ogawa H, Inoue M, Ichinohe T, Atsuta
Marrow
Y, Kanda Y; HLA Working Group of theTransplant
Japan Society for Hematopoietic Cell
Transplantation.

2016

22(11):20 WGP
31-7.
17-12

Unrelated bone marrow transplantation or
immediate umbilical cord blood
214 transplantation for patients with acute
myeloid leukemia in first complete
remission.

Haploidentical and Matched Sibling Donor
Hematopoietic Cell Transplantation for216
Patients with HLA-Homozygous
Haplotypes.

論文タイトル

著者

雑誌名

Yokoyama H, Kanda J, Fuji S, Kim SW,
Fukuda T, Najima Y, Ohno H, Uchida N,
Impact of Human Leukocyte Antigen Allele Ueda Y, Eto T, Iwato K, Kobayashi H,
Biol Blood
Mismatch in Unrelated Bone Marrow
Ozawa Y, Kondo T, Ichinohe T, Atsuta Y,
217
Marrow
Transplantation with Reduced-Intensity
Kanda Y; HLA Working Group of theTransplant
Conditioning Regimen.
Japan Society for Hematopoietic Cell
Transplantation.

Impact of the presence of HLA 1-locus
mismatch and the use of low-dose
218
antithymocyte globulin in unrelated bonemarrow transplantation.

発行
年

刊・号・
頁

2017

23(2):300 WGP
-9.
17-13

Kawamura K, Kanda J, Fuji S, Murata M,
Ikegame K, Yoshioka K, Fukuda T, Ozawa
Y, Uchida N, Iwato K, Sakura T, Hidaka M, Bone Marrow
2017
Hashimoto H, Ichinohe T, Atsuta Y, Kanda Transplant
Y.

業績
番号

52(10):13 WGP
90-8.
17-14

Homozygous HLA-C1 is Associated with
Reduced Risk of Relapse after HLA219
Matched Transplantation in Patients with
Myeloid Leukemia.

Arima N, Kanda J, Tanaka J, Yabe T,
Morishima Y, Kim SW, Najima Y, Ozawa Y, Biol Blood
Eto T, Kanamori H, Mori T, Kobayashi N, Marrow
Kondo T, Nakamae H, Uchida N, Inoue M, Transplant
Fukuda T, Ichinohe T, Atsuta Y, Kanda Y.

201824(4):717 WGP
-25.
17-15

Comparison of HLA Allele Mismatch andAntigen Mismatch in Unrelated Bone
220
Marrow Transplantation in Patients with
Leukemia.

Atsuta Y , Kato S , Morishima Y , Ohashi
K , Fukuda T , Ozawa Y , Eto T , Iwato K ,Biol Blood
Uchida N , Ota S , Onizuka M , Ichinohe T
Marrow, Kanda J , Kanda Y ; HLA Working Group
Transplantof the Japan Society for Hematopoietic
Cell Transplantation.

201925(3):436 WGP
-42.
17-16

HLA discrepancy between graft and host221 rather than that graft and first donor
impact the second transplant outcome.

Maeda Y , Ugai T , Kondo E , Ikegame K ,Murata M , Uchida N , Miyamoto T ,Takahashi S , Ohashi K , Nakamae H ,Haematologic
2019
Fukuda T , Onizuka M , Eto T , Ota S ,aHirokawa M , Ichinohe T , Atsuta Y ,Kanda Y , Kanda J.

104(5):10 WGP
55-61.
17-17

Yokoyama H, Kanda J, Kato S, Kondo E,
Maeda Y, Saji H, Takahashi S, Onizuka M,
Effects of HLA mismatch on
Onishi Y, Ozawa Y, Kanamori H, Ishikawa
Bone Marrow
222 cytomegalovirus reactivation in cord blood J, Ohno Y, Ichinohe T, Takanashi M, Kato
2019
Transplanttransplantation.
K, Atsuta Y, Kanda Y; HLA Working Groupof the Japan Society for Hematopoietic
Cell Transplantation.

54(7):100 WGP
4-12.
17-18

Fujiwara SI, Kanda J, Tatara R, Ogawa H,
Fukuda T, Okumura H, Ohashi K, Iwato K,
Clinical significance of low-dose total body Ueda Y, Ishiyama K, Eto T, Matsuoka KI,
Bone Marrow
223 irradiation in HLA-mismatched reducedNakamae H, Onizuka M, Atsuta Y, Kanda
2019
Transplant
intensity stem cell transplantation.
Y, HLA Working Group of the Japan
Society for Hematopoietic Cell
Transplantation.

54(8):132 WGP
7-36.
17-19

Kanda J, Kawase T, Tanaka H, Kojima H,
Morishima Y, Uchida N, Nagafuji K,
Matsuhashi Y, Ohta T, Onizuka M, Sakura
Biol Blood
T, Takahashi S, Miyakoshi S, Kobayashi H,
Marrow
Eto T, Tanaka J, Ichinohe T, Atsuta Y,
Transplant
Morishima S; HLA Working Group of theJapan Society for Hematopoietic Cell
Transplantation.

2020

26(3):509 WGP
-18.
17-20

Kawase T, Tanaka H, Kojima H, Uchida N,
Ohashi K, Fukuda T, Ozawa Y, Ikegame K,
Impact of High-Frequency HLA Haplotypes
Eto T, Mori T, Miyamoto T, Hidaka M,
Biol Bloodon Clinical Cytomegalovirus Reactivation in
225
Shiratori S, Takanashi M, Atsuta Y,
Marrow
Allogeneic Hematopoietic Stem Cell
Ichinohe T, Kanda Y, Kanda J; HLA
Transplant
Transplantation.
Working Group of the Japan Society for
Hematopoietic Cell Transplantation.

2019

25(12):24 WGP
82-9.
17-21

Effects of Haplotype Matching on
224 Outcomes after Adult Single-Cord Blood
Transplantation.

雑誌名

発行
年

刊・号・
頁

Impact of Homozygous Conserved
Morishima Y, Morishima S, Murata M,
Extended HLA Haplotype on Single Cord Arima N, Uchida N, Sugio Y, Takahashi S, Biol Blood
226 Blood Transplantation: Lessons for
Matsuhashi Y, Onizuka M, Eto T, Nagafuji Marrow
Induced Pluripotent Stem Cell Banking and K, Onishi Y, Inoue M, Atsuta Y, Fukuda T, Transplant
Transplantation in Allogeneic Settings.
Ichinohe T, Kato S, Kanda J.

2020

26(1):132 WGP
-8.
17-22

Fuji S, Miyamura K, Kanda Y, Fukuda T,
Short-term clinical outcomes after HLA 1- Kobayashi T, Ozawa Y, Iwato K, Uchida N,
locus mismatched uPBSCT are similar to Eto T, Ashida T, Mori T, Sawa M, Ichinohe
227
Int J Hematol 2019that after HLA-matched uPBSCT and
T, Atsuta Y, Kanda J; HLA Working GroupuBMT.
of the Japan Society for Hematopoietic
Cell Transplantation.

109(6):68 WGP
4-93.
17-23

Yokoyama H, Morishima Y, Fuji S, Uchida
N, Takahashi S, Onizuka M, Tanaka M,
Impact of HLA Allele Mismatch at HLA-A, Yuju O, Eto T, Ozawa Y, Takada S,
Biol Blood
228 -B, -C, and -DRB1 in Single Cord Blood
Takanashi M, Kato K, Kanda Y, Ichinohe Marrow
Transplantation.
T, Atsuta Y, Kanda J; HLA Working Group Transplantof the Japan Society for Hematopoietic
Cell Transplantation.

2020

26(3):519 WGP
-28.
17-24

Increased Relapse Risk of Acute Lymphoid Arima N, Kanda J, Yabe T, Morishima Y,
Leukemia in Homozygous HLA-C1 Patients Tanaka J, Kako S, Sakaguchi H, Kato M,
229 after HLA-Matched Allogeneic
Ohashi K, Ozawa Y, Fukuda T, Ota S,
Transplantation: A Japanese National
Tachibana T, Onizuka M, Ichinohe T,
Registry Study.
Atsuta Y, Kanda Y.

Biol Blood
Marrow
Transplant2020

26(3):431 WGP
-7.
17-25

Koji Kawamura , Junya Kanda , Kazuteru
Ohashi , Takahiro Fukuda , Koji Iwato ,Influence of HLA 1-3-locus mismatch and Tetsuya Eto , Shin-Ichiro Fujiwara ,230 antithymocyte globulin administration in
Takehiko Mori , Kentaro Fukushima ,unrelated bone marrow transplantation.
Yukiyasu Ozawa , Naoyuki Uchida ,Takashi Ashida , Tatsuo Ichinohe ,Yoshiko Atsuta , Yoshinobu Kanda.

Ann Hematol 2020

99(5):109 WGP
9-110.
17-26

論文タイトルIndividual HLAs influence immunologicalevents in allogeneic stem cell
231
transplantation from HLA-identical sibling
donors.

著者

Satoko Morishima , Takahiro Fukuda ,Noriko Doki , Takehiko Mori , Makoto
Onizuka , Toshihiro Kawakita , Chiaki
Kato , Yukiyasu Ozawa , Masatsugu
Tanaka , Mineo Kurokawa , Tomohiko
Bone Marrow
Kamimura , Masami Inoue , Junji Tanaka , Transplant
Tatsuo Ichinohe , Yoshiko Atsuta , Yasuo
Morishima , HLA Working Group of theJapan Society for Hematopoietic Cell
Transplantation.

in press

業績
番号

WGP
17-27

Kanda J, Ichinohe T, Kato S, Uchida N,
Terakura S, Fukuda T, Hidaka M, Ueda Y,
Unrelated cord blood transplantation vsKondo T, Taniguchi S, Takahashi S,
related transplantation with HLA 1-antigen Nagamura-Inoue T, Tanaka J, Atsuta Y,
232
Leukemia
mismatch in the graft-versus-host
Miyamura K, Kanda Y; Donor/Source
direction.
Working Group and HLA Working Group of
the Japan Society for Hematopoietic Cell
Transplantation.

2013

27(2):286 WGP
-94.
18-1

Kuwatsuka Y, Atsuta Y, Horowitz MM,
Inagaki J, Kanda J, Kato K, Koh K, Zhang
MJ, Eapen M; Center for International
Biol Blood
Blood and Marrow Transplant Research
Marrow(CIBMTR), and Donor/Source and GVHD
Transplant
Working Group of the Japan Society for
Hematopoietic Cell Transplantation(JSHCT).

2014

20(5):662 WGP
-7.
18-2

Graft-versus-host disease and survival
after cord blood transplantation for acute233
leukemia: a comparison of Japaneseversus White populations.

雑誌名

発行
年

刊・号・
頁

Tanaka M, Miyamura K, Terakura S, Imai
Biol Blood
K, Uchida N, Ago H, Sakura T, Eto T,
Marrow
Ohashi K, Fukuda T, Taniguchi S, Mori S,
Transplant
Nagamura-Inoue T, Atsuta Y, Okamoto S.

201521(3):517 WGP
-25.
18-3

Biol Blood
Marrow
Transplant

2016

22(2):330 WGP
-8.
18-4

Kumar R, Kimura F, Ahn KW, Hu ZH,
Kuwatsuka Y, Klein JP, Pasquini M,
Comparing Outcomes with Bone Marrow or Miyamura K, Kato K, Yoshimi A, Inamoto
Peripheral Blood Stem Cells as Graft
Y, Ichinohe T, Wood WA Jr, Wirk B, Seftel Biol Blood
236 Source for Matched Sibling Transplants in M, Rowlings P, Marks DI, Schultz KR,
Marrow
Severe Aplastic Anemia across Different Gupta V, Dedeken L, George B, Cahn JY, Transplant
Economic Regions.
Szer J, Lee JW, Ho AY, Fasth A, Hahn T,
Khera N, Dalal J, Bonfim C, Aljurf M,
Atsuta Y, Saber W.

201622(5):932 WGP
-40.
18-5

Graft-versus-Host Disease after HLAMatched Sibling Bone Marrow orPeripheral Blood Stem Cell
237
Transplantation: Comparison of North
American Caucasian and Japanese
Populations.

Kanda J, Brazauskas R, Hu ZH,
Kuwatsuka Y, Nagafuji K, Kanamori H,
Kanda Y, Miyamura K, Murata M, Fukuda Biol Blood
T, Sakamaki H, Kimura F, Seo S, Aljurf M, Marrow
Yoshimi A, Milone G, Wood WA, Ustun C, Transplant
Hashimi S, Pasquini M, Bonfim C, Dalal J,
Hahn T, Atsuta Y, Saber W.

201622(4):744 WGP
-51.
18-6

Comparison of Donor Sources in
Hematopoietic Stem Cell Transplantation238
for Childhood Acute Leukemia: A
Nationwide Retrospective Study.

Sakaguchi H, Watanabe N, Matsumoto K,
Yabe H, Kato S, Ogawa A, Inagaki J, Goto
H, Koh K, Yoshida N, Kato K, Cho Y,
Biol Blood
Kosaka Y, Takahashi Y, Inoue M, Kato K, Marrow
Atsuta Y, Miyamura K; Donor/Source
Transplant
Working Group of Japan Society of
Hematopoietic Cell Transplantation.

2016

22(12):22 WGP
26-34.
18-7

Kuwatsuka Y, Kanda J, Yamazaki H, Mori
T, Miyamura K, Kako S, Uchida N, Ohashi
A Comparison of Outcomes for Cord Blood K, Ozawa Y, Takahashi Y, Kato C, Iwato
Biol Blood
Transplantation and Unrelated BoneK, Ishiyama K, Kobayashi H, Eto T, Kahata
239
Marrow
Marrow Transplantation in Adult Aplastic K, Kato J, Miyamoto T, Kato K, Mori S,
Transplant
Anemia.
Atsuta Y, Kimura F, Kanda Y; Japan
Society for Hematopoietic Cell
Transplantation.

2016

22(10):18 WGP
36-43.
18-8

Konuma T, Tsukada N, Kanda J, UchidaN, Ohno Y, Miyakoshi S, Kanamori H,
Comparison of transplant outcomes from Hidaka M, Sakura T, Onizuka M,
matched sibling bone marrow or peripheral Kobayashi N, Sawa M, Eto T, Matsuhashi Am J
240
blood stem cell and unrelated cord blood in Y, Kato K, Ichinohe T, Atsuta Y, Miyamura Hematol
patients 50 years or older.
K; Donor/Source Working Group of theJapan Society for Hematopoietic Cell
Transplantation.

2016

91(5):E28 WGP
4-92.
18-9

Kimura F, Kanda J, Ishiyama K, Yabe T,
Yoshifuji K, Fukuda T, Ozawa Y, Iwato K,
Eto T, Mori T, Uchida N, Ota S, Sakura T,
Bone Marrow
Ichinohe T, Atsuta Y, Kanda Y;
2019
Transplant
donor/source working group of the Japan
Society for Hematopoietic Cell
Transplantation.

54(10):16 WGP
76-85.
18-10

論文タイトル

234

Comparison of cord blood transplantation
with unrelated bone marrowtransplantation in patients older than fifty
years.

著者

Terakura S, Atsuta Y, Tsukada N,
Comparison of Outcomes of 8/8 and 7/8
Kobayashi T, Tanaka M, Kanda J, Najima
Allele-Matched Unrelated Bone Marrow
Y, Fukuda T, Uchida N, Takahashi S,
235 Transplantation and Single-Unit Cord
Nagamura-Inoue T, Morishima Y,
Blood Transplantation in Adults with Acute
Miyamura K; Japan Society for
Leukemia.
Hematopoietic Cell Transplantation.

ABO blood type incompatibility lost the
241 unfavorable impact on outcome inunrelated bone marrow transplantation.

業績
番号

雑誌名

発行
年

刊・号・
頁

Kanda J, Hayashi H, Ruggeri A, Kimura F,
Volt F, Takahashi S, Labopin M, Kako S,
Prognostic factors for adult single cord
Tozatto-Maio K, Yano S, Sanz G, Uchidablood transplantation among European andN, Van Lint MT, Kato S, Mohty M,
242 Japanese populations: the
Leukemia
Forcade E, Kanamori H, Sierra J, Ohno Y,
Eurocord/ALWP-EBMT and
Saccardi R, Fukuda T, Ichinohe T,
JSHCT/JDCHCT collaborative study.
Takanashi M, Rocha V, Okamoto S,
Nagler A, Atsuta Y, Gluckman E.

202034(1):128 WGP
-37.
18-11

論文タイトル

Improvement of early mortality in single243 unit cord blood transplantation forJapanese adults from 1998 to 2017.

著者

Konuma T, Kanda J, Inamoto Y, Hayashi
H, Kobayashi S, Uchida N, Sugio Y,
Tanaka M, Kobayashi H, Kouzai Y,
Am JTakahashi S, Eto T, Mukae J, Matsuhashi Hematol
Y, Fukuda T, Takanashi M, Kanda Y,
Atsuta Y, Kimura F.

in press

業績
番号

WGP
18-12

Nobuhiko Imahashi, Seitaro Terakura,
Eisei Kondo, Shinichi Kako, Naoyuki
Uchida, Hikaru Kobayashi, Yoshihiro
Comparison of Reduced-Intensity/Toxicity Inamoto, Hitoshi Sakai, Masatsugu
Conditioning Regimens for Umbilical Cord Tanaka, Jun Ishikawa, Yasuji Kozai, Ken- Bone Marrow
244
2020
Blood Transplantation for Lymphoid
Ichi Matsuoka, Takafumi Kimura, Takahiro Transplant
Malignancies.
Fukuda, Yoshiko Atsuta, Junya Kanda,
Donor/Source Working Group of theJapan Society for Hematopoietic Cell
Transplantation.

55(11):20 WGP
98-108. 18-13

Kotaro Miyao , Seitaro Terakura ,Fumihiko Kimura , Takaaki Konuma ,Koichi Miyamura , Masamitsu Yanada ,Shinichi Kako , Satoko Morhishima ,Updated Comparison of 7/8 HLA AlleleNaoyuki Uchida , Takashi Toya , Yukiyasu
Matched Unrelated Bone Marrow
Biol Blood
Ozawa , Takahiro Fukuda , Masatsugu
245 Transplantation and Single-Unit Umbilical
Marrow
Tanaka , Masashi Sawa , Satoru Takada ,Cord Blood Transplantation as Alternative
Transplant
Shuro Yoshida , Takafumi Kimura , Tatsuo
Donors in Adults with Acute Leukemia.
Ichinohe , Yoshiko Atsuta , Junya Kanda ,Donor/Source Working Group of theJapan Society for Hematopoietic Cell
Transplantation.

2020

26(11):21 WGP
05-14.
18-14

Clinical factors predicting the response of
acute graft-versus-host disease tocorticosteroid therapy: an analysis from246
the GVHD Working Group of the Japan
Society for Hematopoietic Cell
Transplantation.

Murata M, Nakasone H, Kanda J, Nakane
T, Furukawa T, Fukuda T, Mori T,
Biol Blood
Taniguchi S, Eto T, Ohashi K, Hino M,
Marrow
Inoue M, Ogawa H, Atsuta Y, NagamuraTransplant
Inoue T, Yabe H, Morishima Y, Sakamaki
H, Suzuki R.

2013

19(8):118 WGP
3-9.
19-1

A case-control study of bronchiolitis
247 obliterans syndrome following allogeneic
hematopoietic stem cell transplantation.

Nakasone H, Kanda J, Yano S, Atsuta Y,
Ago H, Fukuda T, Kakihana K, Adachi T,
Yujiri T, Taniguchi S, Taguchi J,
Morishima Y, Nagamura T, Sakamaki H,
Mori T, Murata M; GVHD Working Groupof the Japan Society for Hematopoietic
Cell Transplantation.

2013

26(6):631 WGP
-9.
19-2

Kanda J, Nakasone H, Atsuta Y, Toubai T,
Yokoyama H, Fukuda T, Taniguchi S,
Bone Marrow
Ohashi K, Ogawa H, Eto T, Miyamura K,
2014
Transplant
Morishima Y, Nagamura-Inoue T,
Sakamaki H, Murata M.

49(2):228 WGP
-35.
19-3

Nakasone H, Fukuda T, Kanda J, Mori T,
Yano S, Kobayashi T, Miyamura K, Eto T,
Impact of conditioning intensity and TBI on Kanamori H, Iwato K, Uchida N, Mori S,
Bone Marrow
249 acute GVHD after hematopoietic cell
Nagamura-Inoue T, Ichinohe T, Atsuta Y,
2015
Transplanttransplantation.
Teshima T, Murata M; GVHD working
group of the Japan Society of
Hematopoietic Cell Transplantation.

50(4):559 WGP
-65.
19-4

248

Risk factors and organ involvement ofchronic GVHD in Japan.

Transpl Int

雑誌名

発行
年

刊・号・
頁

Nakane T, Fukuda T, Kanda J, Taniguchi
S, Eto T, Ohashi K, Nakamae H, Kurokawa Leuk
M, Mori T, Morishima Y, Nagamura-Inoue Lymphoma
T, Sakamaki H, Atsuta Y, Murata M.

2015

56(8):239 WGP
2-7.
19-5

Umeda K, Adachi S, Tanaka S, Ogawa A,
Hatakeyama N, Kudo K, Sakata N,
Comparison of continuous and twice-daily Igarashi S, Ohshima K, Hyakuna N, Chin
infusions of cyclosporine A for graftM, Goto H, Takahashi Y, Azuma E, Koh K,
Pediatr Blood
251 versus-host-disease prophylaxis in
Sawada A, Kato K, Inoue M, Atsuta Y,
2015
Cancerpediatric hematopoietic stem cell
Takami A, Murata M; on behalf of thetransplantation.
GVHD Working Group of the Japan
Society for Hematopoietic Cell
Transplantation.

62(2):291 WGP
-8.
19-6

Sakai R, Taguri M, Oshima K, Mori T, Ago
H, Adachi S, Morita S, Taniguchi S,
Fukuda T, Ohashi K, Eto T, Miyamura K,
Int J Hematol 2016
Iwato K, Kobayashi N, Kanamori H,
Morishima Y, Nagamura-Inoue T,
Sakamaki H, Atsuta Y, Murata M.

103(3):32 WGP
2-33.
19-7

論文タイトル
Age influences post-graft-versus-hostdisease non-relapse mortality in adults
250 with acute graft-versus-host disease ofvarying severity following allogeneic
hematopoietic cell transplant.

A comparison of tacrolimus andcyclosporine combined with methotrexate
252 for graft-versus-host disease prophylaxis,
stratified by stem cell source: aretrospective nationwide survey.

著者

Arai Y, Kanda J, Nakasone H, Kondo T,
Risk factors and prognosis of hepatic
Uchida N, Fukuda T, Ohashi K, Kaida K,
253 acute GvHD after allogeneic hematopoietic Iwato K, Eto T, Kanda Y, Nakamae H,cell transplantation.
Nagamura-Inoue T, Morishima Y,
Hirokawa M, Atsuta Y, Murata M.

Bone Marrow
2016
Transplant

業績
番号51(1):96- WGP
102.
19-8

Impact of graft-versus-host disease on
254 outcomes after unrelated cord bloodtransplantation.

Kanda J, Morishima Y, Terakura S, Wake
A, Uchida N, Takahashi S, Ono Y, Onishi
Y, Kanamori H, Aotsuka N, Ozawa Y,
Leukemia
Ogawa H, Sakura T, Ohashi K, Ichinohe T,
Kato K, Atsuta Y, Teshima T, Murata M.

201731(3):663 WGP
-8.
19-9

Low-dose thymoglobulin as second-line
255 treatment for steroid-resistant acute
GvHD: an analysis of the JSHCT.

Murata M, Ikegame K, Morishita Y, Ogawa
H, Kaida K, Nakamae H, Ikeda T, Nishida
T, Inoue M, Eto T, Kubo K, Sakura T, Mori Bone Marrow
2017
T, Uchida N, Ashida T, Matsuhashi Y,
TransplantMiyazaki Y, Ichinohe T, Atsuta Y, TeshimaT.

52(2):252 WGP
-7.
19-10

Exploratory research for optimal GvHD
prophylaxis after single unit CBT in adults:
256 short-term methotrexate reduced theincidence of severe GvHD more than
mycophenolate mofetil.

Terakura S, Wake A, Inamoto Y, Murata
M, Sakai R, Yamaguchi T, Takahashi S,
Uchida N, Onishi Y, Ohashi K, Ozawa Y,
Kanamori H, Yamaguchi H, Fukuda T,
Ichinohe T, Takanashi M, Atsuta Y,
Teshima T.

Bone Marrow
2017
Transplant52(3):423 WGP
-30.
19-11

Inamoto Y, Kimura F, Kanda J, Sugita J,
Comparison of graft-versus-host diseaseIkegame K, Nakasone H, Nannya Y,
free, relapse-free survival according to a
Uchida N, Fukuda T, Yoshioka K, Ozawa Haematologic
257 variety of graft sources: antithymocyte
2016
Y, Kawano I, Atsuta Y, Kato K, Ichinohe T, a
globulin and single cord blood provide
Inoue M, Teshima T; JSHCT GVHD
favorable outcomes in some subgroups.
Working Group.

101(12):1 WGP
592-602. 19-12

Arai Y, Kondo T, Yamazaki H, Takenaka K,
Sugita J, Kobayashi T, Ozawa Y, UchidaN, Iwato K, Kobayashi N, Takahashi Y,
Haematologic
2016
Ishiyama K, Fukuda T, Ichinohe T, Atsuta a
Y, Mori T, Teshima T; Japan Society for
Hematopoietic Cell Transplantation.

101(5):64 WGP
4-52.
19-13

Allogeneic unrelated bone marrowtransplantation from older donors results258
in worse prognosis in recipients withaplastic anemia.

論文タイトル

著者

雑誌名

発行
年

Terakura S, Kuwatsuka Y, Yamasaki S,
Wake A, Kanda J, Inamoto Y, Mizuta S,
GvHD prophylaxis after single-unit reduced Yamaguchi T, Uchida N, Kouzai Y,
intensity conditioning cord blood
Aotsuka N, Ogawa H, Kanamori H,
Bone Marrow259
2017transplantation in adults with acuteNishiwaki K, Miyakoshi S, Onizuka M,
Transplantleukemia.
Amano I, Fukuda T, Ichinohe T, Atsuta Y,
Murata M, Teshima T.

刊・号・
頁

業績
番号

52(9):126 WGP
1-7.
19-14

Impacts of thymoglobulin in patients with
260 acute leukemia in remission undergoing
allogeneic HSCT from different donors.

Wakamatsu M, Terakura S, Ohashi K,
Fukuda T, Ozawa Y, Kanamori H, Sawa M,
Uchida N, Ota S, Matsushita A, Kanda Y,
Blood
Nakamae H, Ichinohe T, Kato K, Murata
Advances
M, Atsuta Y, Teshima T; GVHD Working
Group of the Japan Society for
Hematopoietic Cell Transplantation.

2019

3(2):105- WGP
15.
19-15

Effect of Graft-Versus-Host Disease on
261 Outcomes After Pediatric Single Cord
Blood Transplantation.

Junya Kanda, Katsutsugu Umeda, Koji
Kato, Makoto Murata, Junichi Sugita,
Souichi Adachi, Katsuyoshi Koh, Maiko
Noguchi, Hiroaki Goto, Nao Yoshida, Maho Bone Marrow
2020
Sato, Yuhki Koga, Tsukasa Hori, Yuko
TransplantCho, Atsushi Ogawa, Masami Inoue,
Yoshiko Hashii, Yoshiko Atsuta, Takanori
Teshima, JSHCT GVHD Working Group.

55(7):143 WGP
0-7.
19-16

Impact of hepatitis C virus infection onclinical outcome in recipients after
262
allogeneic hematopoietic celltransplantation.

Nakasone H, Kurosawa S, Yakushijin K,
Taniguchi S, Murata M, Ikegame K,
Kobayashi T, Eto T, Miyamura K,
Sakamaki H, Morishima Y, Nagamura T,
Suzuki R, Fukuda T.

2013

88(6):477 WGP
-84.
20-1

Pre-transplant risk factors for cryptogenic Nakasone H, Onizuka M, Suzuki N, Fujii N,
organizing pneumonia/bronchiolitis
Taniguchi S, Kakihana K, Ogawa H,
Bone Marrow
263
2013
obliterans organizing pneumonia after
Miyamura K, Eto T, Sakamaki H, Yabe H, Transplant
hematopoietic cell transplantation.
Morishima Y, Kato K, Suzuki R, Fukuda T.

48(10):13 WGP
17-23.
20-2

Salvage allogeneic hematopoietic SCT for
264
primary graft failure in children.

Kato M, Matsumoto K, Suzuki R, Yabe H,
Inoue M, Kigasawa H, Inagaki J, Koh K,
Bone Marrow2013
Hashii Y, Tauchi H, Suminoe A, Kikuta A, Transplant
Sakamaki H, Kawa K, Kato K, Fukuda T.

48(9):117 WGP
3-8.
20-3

Impact of pretransplant body mass index
265 on the clinical outcome after allogeneic
hematopoietic SCT.

Fuji S, Takano K, Mori T, Eto T, Taniguchi
Bone Marrow
S, Ohashi K, Sakamaki H, Morishima Y,
2014
Transplant
Kato K, Miyamura K, Suzuki R, Fukuda T.

49(12):15 WGP
05-12.
20-4

Cytomegalovirus Reactivation after
Allogeneic Hematopoietic Stem Cell
Transplantation is Associated with a
Reduced Risk of Relapse in Patients with
266 Acute Myeloid Leukemia Who Survived to
Day 100 after Transplantation: The Japan
Society for Hematopoietic Cell
Transplantation Transplantation-related
Complication Working Group.

Takenaka K, Nishida T, Asano-Mori Y,
Oshima K, Ohashi K, Mori T, Kanamori H, Biol Blood
Miyamura K, Kato C, Kobayashi N, Uchida Marrow
N, Nakamae H, Ichinohe T, Morishima Y, Transplant
Suzuki R, Yamaguchi T, Fukuda T.

2015

21(11):20 WGP
08-16.
20-5

Bone Marrow
2015
Transplant50(4):553 WGP
-8.
20-6

Yakushijin K, Atsuta Y, Doki N, Yokota A,
Sinusoidal obstruction syndrome after
Kanamori H, Miyamoto T, Ohwada C,
allogeneic hematopoietic stem cell
Miyamura K, Nawa Y, Kurokawa M,
Bone Marrow
268
2016transplantation: Incidence, risk factors and Mizuno I, Mori T, Onizuka M, Taguchi J, Transplant
outcomes.
Ichinohe T, Yabe H, Morishima Y, Kato K,
Suzuki R, Fukuda T.

51(3):403 WGP
-9.
20-7

Pre-transplant diabetes mellitus is a risk
Takano K, Fuji S, Uchida N, Ogawa H,
factor for non-relapse mortality, especially
267
Ohashi K, Eto T, Sakamaki H, Morishima
infection-related mortality, after allogeneic
Y, Kato K, Suzuki R, Fukuda T.
hematopoietic SCT.

Am J
Hematol論文タイトル

雑誌名

発行
年

刊・号・
頁

Leukemia

201630(8):174 WGP
2-5.
20-8

Nakasone H, Fuji S, Yakushijin K, Onizuka
M, Shinohara A, Ohashi K, Miyamura K,
Uchida N, Takanashi M, Ichinohe T,
Am J
Atsuta Y, Fukuda T, Ogata M;
Hematol
Complication Working Group of JapaneseSociety for Hematopoietic Cell
Transplantation.

2017

92(2):171 WGP
-8.
20-9

著者

Kato M, Yamashita T, Suzuki R,
Donor cell-derived hematologic
Matsumoto K, Nishimori H, Takahashi S,
269 malignancy: A survey by the Japan society Iwato K, Nakaseko C, Kondo T, Imada K,
for hematopoietic cell transplantation.
Kimura F, Ichinohe T, Hashii Y, Kato K,
Atsuta Y, Taniguchi S, Fukuda T.
Impact of total body irradiation on
successful neutrophil engraftment in
270
unrelated bone marrow or cord bloodtransplantation.

Clinical characteristics and outcome ofhuman herpesvirus-6 encephalitis after
271
allogeneic hematopoietic stem celltransplantation.

BM is preferred over PBSCs in
272 transplantation from an HLA-matched
related female donor to a male recipient.

Ogata M, Oshima K, Ikebe T, Takano K,
Kanamori H, Kondo T, Ueda Y, Mori T,
Hashimoto H, Ogawa H, Eto T, Ueki T,
Bone Marrow
2017
Miyamoto T, Ichinohe T, Atsuta Y, Fukuda Transplant
T.
Nakasone H, Kawamura K, Yakushijin K,
Shinohara A, Tanaka M, Ohashi K, Ota S,
Blood
Uchida N, Fukuda T, Nakamae H,
Advances
Matsuoka KI, Kanda J, Ichinohe T, Atsuta
Y, Inamoto Y, Seo S, Kimura F, Ogata M.

業績
番号52(11):15 WGP
63-70.
20-10

2019

3(11):175 WGP
0-60.
20-11

Kato M, Nakasone H, Nakano N, Fuji S,
Shinohara A, Yokoyama H, Sakashita K,
Hori T, Takahashi S, Nara M, Kanda Y,
Clinical course of autologous recovery with
Mori T, Takita J, Kawaguchi H, Kawakita Bone Marrow
273 chromosomal abnormalities after allogeneic
2020
T, Ichinohe T, Fukuda T, Atsuta Y, Ogata Transplant
hematopoietic stem cell transplantation.
M; Transplantation Complication Working
Group of the Japan Society for
Hematopoietic Cell Transplantation.

55(6):102 WGP
3-8.
20-12

Risk Factors and Predictive Scoring
System For Post-Transplant
274
Lymphoproliferative Disorder after
Hematopoietic Stem Cell Transplantation.

Fujimoto A, Hiramoto N, Yamasaki S,
Inamoto Y, Uchida N, Maeda T, Mori T,
Biol Blood
Kanda Y, Kondo T, Shiratori S, Miyakoshi
Marrow
S, Ishiyama K, Ikegame K, Matsuhashi Y,
Transplant
Tanaka J, Ichinohe T, Atsuta Y, Ogata M,
Suzuki R.

201925(7):144 WGP
1-9.
20-13

Low incidence of post-transplant
lymphoproliferative disorder after
275 allogeneic stem cell transplantation inpatients with lymphoma treated withrituximab.

Fujimoto A, Hiramoto N, Yamasaki S,
Inamoto Y, Ogata M, Sugio Y, Fukuda T,
Uchida N, Ikegame K, Matsuoka KI,
Shiratori S, Kondo T, Miyamoto T, Eto T, Hematological
2020
Ichinohe T, Kanda Y, Atsuta Y, Suzuki R; Oncology
Complication Working Group of the Japan
Society for Hematopoietic Cell
Transplantation.

38(2):146 WGP
-52.
20-14

Impact of pretransplant donor-specificFuji S, Oshima K, Ohashi K, Sawa M,
anti-HLA antibodies on cord blood
Saito T, Eto T, Tanaka M, Onizuka M,
transplantation on behalf of the Transplant
Bone Marrow
276
Nakamae H, Shiratori S, Ozawa Y, Hidaka
2020
Complications Working Group of Japan
Transplant
M, Nagamura-Inoue T, Tanaka H, Fukuda
Society for Hematopoietic Cell
T, Ichinohe T, Atsuta Y, Ogata M.
Transplantation.

55(4):722 WGP
-8.
20-15

Harada K, Fuji S, Seo S, Kanda J, Ueki T,
Kimura F, Kato K, Uchida N, Ikegame K,
Onizuka M, Matsuoka KI, Doki N,
Kawakita T, Onishi Y, Yano S, Fukuda T, Bone Marrow
2020
Takanashi M, Kanda Y, Atsuta Y, Ogata
Transplant
M; transplant complications working groupof the Japan Society for Hematopoietic
Cell Transplantation.

55(9):178 WGP
4-95.
20-16

Comparison of the outcomes after
haploidentical and cord blood salvage
277 transplantations for graft failure following
allogeneic hematopoietic stem celltransplantation.

論文タイトルComparison of immunosuppressantregimens in salvage cord blood
278 transplantation for graft failure after
allogeneic hematopoietic stem celltransplantation.

著者

雑誌名

Kaito Harada , Shigeo Fuji , Sachiko Seo ,Naoyuki Uchida , Toshiro Kawakita ,Shingo Yano , Yukiyasu Ozawa , Satoshi
Yoshioka , Yasushi Onishi , Yuma Noguchi, Makoto Onizuka , Yoshiko Matsuhashi ,Takafumi Kimura , Tatsuo Ichinohe ,Bone Marrow
Yoshiko Atsuta , Transplant
2021
Transplant
Complications Working Group of theJapan Society for Hematopoietic Cell
Transplantation; GVHD Working Group of
the Japan Society for Hematopoietic Cell
Transplantation; Seitaro Terakura , Hideki
Nakasone.

Atsuta Y, Hirakawa A, Nakasone H,
Kurosawa S, Oshima K, Sakai R, Ohashi
K, Takahashi S, Mori T, Ozawa Y, Fukuda
Late Mortality and Causes of Death among
Biol Blood
T, Kanamori H, Morishima Y, Kato K, Yabe
279 Long-Term Survivors after Allogeneic
Marrow
H, Sakamaki H, Taniguchi S, Yamashita T;
Stem Cell Transplantation.
Transplant
Late Effect and Quality of Life Working
Group of the Japan Society for
Hematopoietic Cell Transplantation.

Outcomes of patients who developed
280 subsequent solid cancer after
hematopoietic cell transplantation.

発行
年

Inamoto Y, Matsuda T, Tabuchi K,
Kurosawa S, Nakasone H, Nishimori H,
Yamasaki S, Doki N, Iwato K, Mori T,
Takahashi S, Yabe H, Kohno A, Nakamae
H, Sakura T, Hashimoto H, Sugita J, Ago
Blood
H, Fukuda T, Ichinohe T, Atsuta Y,
Advances
Yamashita T; Japan Society for
Hematopoietic Cell Transplantation Late
Effects and Quality of Life Working
Group.

刊・号・
頁

業績
番号

56(2):400 WGP
-10.
20-17

2016

22(9):170 WGP
2-9.
21-1

2018

2(15):190 WGP
1-13.
21-2